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SALTS OF 3-AZABICYCLOC3.3.J> NONANES AS 
ARTIARRHYTHMIC AGE!'I.TS, AND 
PRECURSORS THEREOF CROSS REFERENCE 
TO RELATED APPLICA TIOS 
ties. Potent analgesic and antitusive characteristics as 
well as antagonism to analgesic effects and to narcolic 
action have been observed, depending upon the groups 
attached to the basic structure. In addition. some exam-
This applica1ion is a continuation-in-part of Ser. No. 
07/435,976 filed Nov. 13, 1989, now U.S. Pat. No. 
5,084,572. 
BACKGROUND OF THE INVENTION 
I. Field of the Invention 
5 pies have displayed sedative action as well as antipy-
retic and hypoglycemic activity. Simple 3-ABN has 
been reported to be effective against influenza infection. 
Some derivatives have recorded antiarrhythmic proper-
ties. Certain sulfur-substituted, as well as selenium-sub-
This invention relales to anliarrhythmic composi-
tions. Specifically. this invention relates to certain de-
rivatives of 3-azabicyclo[J.3. l]nonanes. 
2. Description of the Prior Art 
10 stituted examples, have been reported as accessible via a 
Mannich reaction or a modified Mannich reaction. In 
U.S. Pat. No. 4,581.361 and U.S. Pat. No. 4.778,892, for 
example. such malerials are disclosed and claimed as 
antiarrhythmic agents. 
15 
3-Azabicyclo[3.3. l]nonanes with heteroatoms such as 
N, S, and O at the 7-position are known and docu-
mented in the chemical literature. A review in Chemical 
Reviews, Volume 81, No. 2, pages 149-174 (1981), enti-
SUMMARY OF THE INVENTION 
The present invention involves novel derivatives of 
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tied "Chemistry of 3-Azabicyclo[3.3. l]nonanes" by R. 55 
Jeyaraman and S. Avila, covers the synthesis, reactions 
and stereochemistry of the title compounds. The review 
acknowledges the close resemblance of 3-azabicy-
clo[3.3. l]nonanes (3-ABN) to aza- and diazaadaman-
tanes in conformation and stereochernistry, and this has 60 
caused progress in the chemistry of the title compounds. 
The review further acknowledges that 3-ABN systems 
can be obtained by a Mannich, or modified Mannich, 
reaction involving a condensation of ketones or alde-
hydes with a primary amine under relatively mild con- 65 
ditions. Thus, the availability of a variety of ketones or 
aldehydes has prompted studies on 3-ABNs. 
The present invention also provides for novel inter-
mediates of the class of 3-azabicyclo[3.3. I ]nonan-9-ones 
having the formula: 
According to the chemical literature, a few deriva-








































The invention further provides additional 3-azabicy-
clo[3.3. l]nonanes of the formula: 
5 
-continued 
b ~ 4 1--,----, 
Y 9Z N-RHX 
\..._LI 
8 I Qi 
(41) 
Wherein the 3-position in general structures (39-41) is 
nitrogen (as specifically in (l-38)], the 7-position in-
lO eludes nitrogen [as specifically in (l-7), (12), (17), (19), 
(21-24), and (30-37)], su1fur [as specifically in (8- 11 ), 
(15), (16), (18), and (25-29)], and carbon [as specifically 
in (13), (14), (20), and (38)]. With nitrogen in the 3- or 
7-position, a N-C bond is always present except for 
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has an N-S bond. The 9-position can be preferably 
unsubstituted [as specifically in (1)-(10), (13), (15), (17), 
and (27)-(38)], 9-one [as specifically in (18)-(26)], 9,9-
dimethoxy [as specifically in (11), (12), and (16)], or a 
20 1,3-dithiolane [as specifically in (14) and (38)]. The al-
kylated nitrogen atom at the 3-position [as specifically 
in (1)-(16)] and their corresponding tertiary amine acid 
salts (hydroperchlorate, HCI, HBr, H2SO4, citrate, and 
fumarate] are included along with a system containing 
25 an alkylated nitrogen at the 7-position as in (17) and the 
corresponding salts. 
These compounds are the active ingredients for po-
tential drugs and/or intermediates for the active ingre-
30 dients of potential drugs to use in the treatment of disor-
ders of the heart. They exhibit good activity in animal 
models and as such are viable candidates to control 
life-threatening arrhythmias found in humans who ex-
perience heart attacks or major infarctions of the heart. 
Typically, the 9-one systems shown by the general 
Specifically, the invention relates to the above salts 
(I)-(17) of certain 3-azabicyclo(3.3. l]nonanes and pre- 40 
cursors (18)-(38) as used in controlling antiarrhythmic 
processes. Thus, it is the object of the present invention 
35 formula (39) [as specifically in (18)-(26)] are synthesized 
by the reaction of a tetrahydro-4-heteracyclohexanone 
in the presence of an aldehyde and amine or ammonium 
salt in accordance with a Mannich or Mannich type 
reaction. For example, and as illustrated in the follow-
ing reaction scheme A, 1-isopropyl-4-piperidinone (42) 
[or 1-benzyl-4-piperidinone (43) or 4-thianone (44)] was 
allowed to react with benzylamine, 4-chlorobenzyla-
mine, 3,4-dimethoxybenzylamine, 3,4,5-trimethoxyben-
zylamine, and the like with paraformaldehyde in the 
presence of acetic acid/methanol to produce the 3-
azabicyclo[3. 3.1 )nonan-9-ones (39) (representative ex-
amples are (18), (19), and (21)-(24)]. The ketone (39) is 
then reduced with hydrazine hydrate in triethylene 
to provide novel compositions that display biological 
activity. Fulfillment of this object and the presence and 45 
fulfillment of other objects will be apparent upon com-
plete reading of the specifications and claims. 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
The chemical compositions according to the pre-
ferred embodiments of this invention are heteronuclear 
ring organic compounds based on the 3-azabicy-
clo(3.3. l)nonane structures as follows: 
6 , 4 
Y~N-R 
(39) 
I I 2 
6 ' 4 I \ \ 
(40) 
y 9Z N-R 
\ t. I • I 2 
50 glycol/potassium hydroxide media to give members of 
(40) which could be reacted with perchloric acid, hy-
drochloric acid, hydrobromic acid, sulfuric acid, citric 
acid, or fumaric acid in benzene, ether, and/or isopro-
pyl alcohol to yield the corresponding hydroperchlo-
55 rate, hydrochloride, hydrosulfate, citrate, or fumarate 
derivative (41). Related examples where Y is benzyl or 
sulfur follow similarly. Thus the method is applicable to 
obtain members of (18)-(26), with the exception of (20) 
which was prepared from 
60 
REACTION SCHEME A 
+ 
65 
Y s (li)C)2CHN, PHCH2N, S 





REACTIOS SCHEME A 
Rr-H1/H1C=OIHOA,/H3COH ~ (39) 
H1!'.1'H1IKOH 
L HCI04/sohent TEG/HzO 
(41) <IE-.;;"------- (40) 
REACTIO!'. SCHE!>!E C 
HCO,SH.ilH ,COH 
✓--1-0-,;-P .... d_/ __ C_/h_e_at--)~ (40J {R = HJ 
S Y NCH1Ar 
........... I. HC02NH4IH_,COH 
IOt;; Pd!C/heat ), (40) [R = 
2. ArC(O)CI or ArC(O) or 
ArS02CI ArSO:] 
10 
the enam1ne in scheme B starting from (43). The co-
lHCIO.v reactant with (43) to give (20) is made by 
REACTION SCHEME B 









(31) as representative examples, are isolable directly 
from the reaction mixture after workup. Direct aroyla-
tion or sulfonation of these types of intermediates ( 40) in 
20 a two-phase system under modified Schotten-Baumann 
conditions, or phase transfer conditions, leads to amide 
members of (39) [(29), (32)-(35), and (36) are representa-
tive examples]. Treatmenl of these latter amide mem-
bers of (40), such as (32)-(35) and related systems, with 
25 perchloric acid, HCI, HBr, H2S04, citric acid, or fu-
maric acid in benzene, ether, and/or isopropyl alcohol 
produces salts (41) illustrated by (1)-(4) as representa-
tive examples. 
Ketal formation from members of (39), using metha-
JO nol or 1,2-ethanedithiol, under standard conditions, 
produced members of (40), such as illustrated with (38) 
as a representative example, or, after treatment with 
perchloric acid, HCI, HBr, H2S04, citric or fumaric 
35 acid, produced members of(4I) such as illustrated with 
(11), (12), (14), and (16) as representative examples. 
Since oxidation products are viable candidates as 
treatmenl of ester (45) with hydrobromic acid to give 40 
potential metabolites from use of these compounds in 
animals, including humans, oxidation of specific sites 
was performed. As an example, oxidation of (37) illus-
trates the introduction of an oxygen atom alpha to the acid (46) under standard conditions. Esterification of 
(46) under the usual conditions produced dibromide 
(47) which was condensed with the enamine in the 
presence of triethylamine in acetonitrile to yield ketone 45 
(20) under the usual conditions. 
Reduction of the ketones in scheme A, including 
ketone (20), via WolfT-Kishner conditions, as illustrated 50 
with hydrazine/KOH in triethylene glycol, leads to 
amines of general formula (40) [specifically (27), (30), 
nitrogen when treated with Ru02xH20/Nal04 in a 
water/carbon tetrachloride mixture to produce lactam 
(17). Moreover, oxidation of sulfur to give members of 
(41), with sulfoxides (10) and (16) as representative 
examples, can lead to potential metabolites. Salt forma-
tion is again effected by the method outlined previously 
for members of (41). 
EXAMPLE I 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonan-9-one (18) 
Ketone (18) was prepared by the method in U.S. Pat. 
No. 4,581,361. 
EXAMPLE II 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonane (27) 
and (37) are representative examples]. Addition of per-
chloric acid [or HCl, HBr, H2S04, citric acid, or fu- 55 
maric acid] in benzene or isopropyl alcohol gives mem-
bers of general formula (41) [(5)-(9), and (13) are repre- This amine (27) was prepared from ketone ( 18) by the 
method of Bailey, Ill, et. al. J. Med. Chem., vol. 27(6) 
60 pp. 758-767 (1984). 
sentative examples). 
In reaction scheme C, members of (40) [representa-
tive examples are (28), (29), (31), and (32)-(36)] were 
obtained as outlined. Specific members of the family of 
(40) with an N-H bond [note these examples are repre- 65 
sentative starting materials for the amide systems], 




This amine salt was prepared from amine (27) by the 
method of Bailey," III, et. al. J. Med. Chem., vol. 27(6) 






3-Thia-7-azabicyclo[ 3.3. I ]nonane (28) 7-Benz y l-3-isopropy l-3, 7-diazabicyclo[ 3. 3. I ]nonan-
A 50-mL, three-necked, round-bottomed flask was 9-one (21) s 
equipped with a magnetic stirrer. a heating mantle, a A 500-mL, three-necked, round-bottomed flask was 
standard condenser with a N2 inlet and two glass stop- equipped with a magnetic stirrer, a heating mantle, a 
pers. In one portion, anhydrous HCO2NH4 ( 1.11 g, 17.1 250-mL addition funnel, a standard condenser with a 
mmol) was added under N2 to a mixture of the amine Ni inlet and a glass stopper. A mixture of benzylamine 
(27, 0.90 g. 3.86 mmol) and IO'n Pd/C (0.90 g) in anhy-
drous CH3OH (25 mL). With stirring, the mixture was JO (10.7 l g, IOO mmol), HCI <37%, 9-86 g, IOO mmol), 
brought to reflux for 30 min, filtered through a Celite glacial acetic acid (3.0 g, 50 mmol) and paraformalde-
pad on a fritted funnel (which was washed thoroughly hyde (6.31 g, 210 mmol) in deoxygenated (N2 bubbled in 
with CHiCli), and then concentrated to give a gummy for 1 h) CH3OH (100 mL) was stirred at reflux for 15 
oil with suspended solid. This material was again dis- min under N2. A solution of 1-isopropyl-4-piperidinone 
solved in CH2Cl2 (~ 15 rnL), and the suspension was 15 (42, 14.12 g, 100 rnmol) and glacial acetic acid (6.0 g, 
filtered to remove any unreacted ammonium formate. 100 mrnol) in CH3OH (100 mL) was then added drop-
The filtrate was then concentrated to near saturation wise to the mixture over 30 min, followed by stirring at 
and placed in a diffusion chamber of ether overnight. reflux for an additional 18.5 h. Concentration of the 
Crude amine (28) became an oil; however, the mother 
20 
solution gave an oil which was redissolved in H2O (100 
liquor, containing predominantly starting material, mL). An ether extract (100 mL) of this acidic solution 
could be decanted. Chromatography of the oil em- was discarded. Basicification (pH~ 13) of the water 
ployed a gradient elution of CH3OH/CH2Ch (300 mL layer was achieved by the addition of 10% NaOH, 
of 10% CH3OH/CH2Cl2. 50 mL of 20% resulting in the formation of a milky suspension which 
CH3OH/CH2Cl2, 100 mL of 50% CH3OH/CH2Cl2, 25 was extracted (ether, 4X60 mL). Combined extracts 
and 100 mL ofCH3OH) on silica gel (35 g, l.S cmX 62 were dried (Na2SO4, I h), filtered, and concentrated to 
cm) and afforded o. 32 g <56-9%) of amine <28) a viscous red oil, which, when distilled (175°-185° 
(RJ= 0.11, 10% CH 3OH/CH2Ch) as a light, gummy _ ~ . . 
solid which was used without further purification. IH C./IO · mm ~g~, afforded a l~ght yellow oil _os.6 g, 
NMR (DCCh) 61.84, 2.04 (two bd. 2H, H(9)]. 2.31 (bs, 57.2%) that sohd1fied when refngerated at - 10 C.; mp 
2H. H( 1,5)). i.80 [bd, 2H, H(2,4)ax, J = 12.3 Hz). 3.20 30 46° -47.5° C. This solid could be recrystallized (pentane) 
[bd. 2H. H(2.4)eq, J= 13.7 Hz], 3.45 [m, 2H, H(6,8)ax], to give an analytical sample of ketone (21); mp 49°-50° 
3.73 [bd. 2H. H(6,8)eq, J= 13.2 Hz]. 7.59 (bs. 1H, N-H); C. IR (KBr) cm- 1 3095, 3070, 3035 (Ar-H), 2975, 
llC NMR (DCCl3) ppm 24.88 [d, C(l,5)). 29.79 [t, C(9)), 2900, 2820 (C-H), 1745 (C=O), 1605, 1495 (C=C), 
32.17 {t, C(2.4)), 47.8 (1, C(6,8)]. 35 740, 700 (C-H out of plane, mono); 
1H NMR (DCCl3) 
61.02 (d, 6H, CH3), 2.58 [bs, 2H, H(l,5)]. 2.87 [m, SH, 
ring protons and CH(CH3)2], 3.03 (dd, 4H, ring pro-
tons), 3.53 (s, 2H, ArCH2), 7.30 (m, SH, Ar-H); 13C 
NMR (DCCl3) ppm 18.25 (CH3), 46.93 [C(l,5)], 53.41 
[CH(CH3)2], 53.71 (C(2,4)], 58.07 [C(6,8)], 61.25 
(ArCH2), 127.09, 128.25, 128.69, 138.67 (Ar-C), 215.20 
(C=-0); 15N NMR (DCCl3) ppm 39.25 [N(7)], 40.80 
[N(3)). Anal. Calcd. for C11H24N2O: C, 74.96; H, 8.88; 
N, 10.28. Found: C, 75.18; H, 8.61; N, 10.24. 
EXAMPLE V 
7-Benzoyl-3-thia-7-azabicyclo[3.3. l ]nonane (29) 
A 10-mL. two-necked, round-bottomed flask was 
equipped with a magnetic stirrer, an ice bath, a standard 40 
condenser with a N2 inlet, and a glass stopper. To a 
chilled (5° C.) solution of NaOH pellets (0.1 g, 2.38 
mmol) in H2O (1.7 mL) was added a solution of the 
amine (28, 0.17 g. 1.19 mmol) in CH2Cli (1 mL). This 
was followed by the dropwise addition of a solution of 45 
benzoyl chloride (0.2 g, 1.43 mmol) over ~ 5 min. After 
stirring for 30 min at O' -5 • C., 30 min at RT, and then 15 
min over a steam bath, the mixture was diluted with 
H2O (15 mL), and the mixture was extracted (CH2Cl2, 
EXAMPLE VII 
7-Benzyl-3-isopropyl-3, 7-diazabicyclo[3.3.1 ]nonane 
(30) 
3X IS rnL). Combining the extracts, drying (Na2SO4, 50 To a mixture of KOH pellets (85%, l 1.62 g, 176 
overnight), filtering, and concentrating the solution mmol) and the ketone (21) (6.0 g, 22 mmol) in triethyl-
gave a viscous yellow oil. Chromatography of the oil on ene glycol (JOO mL) was added hydrazine (95%, 2.97 g, 
alumina (38 g, 2.4 cm X 17 cm) employed ethyl acetate 88 mmol) in one portion in a 200-mL, jacketed flask 
as eluant and afforded amide (29) (RJ=0.47) as white equipped with a magnetic stirrer, a ·heating mantle, a 
crystals (157 mg, 53.3%); mp 95"-96" C. IR (KBr) 55 standard condenser, a lower take-off condenser with a 
cm-I 3065, 3045 (Ar C-H), 3000, 2985, 2940, 2910, N2 inlet, and two glass stoppers. A heating temperature 
2855, 2835 (C-H), 1635 (C=O), 745, 720 (C-H out of of 200• -210" C. for 4 h under N2 was produced by boil-
plane, mono); 1H NMR (DCCl3) 61.78-1.93 [m, 3H, · t· (b 207, C) · h · k Coot· f h H(9) and H(l)]. 2. 15 [bs, IH, H(S)], 2.39 [d, lH, H(4)ax, mg t~tra m P · m t e Jac et. . . mg o. t e 
J= 13.9 Hz], 2.77 [d, lH, H(6)ax, J = 12_3 Hz], 3_ 12_3_21 60 solution to RT was foll~wed by the add1t1on of chilled 
{rn, 3H, H(4)..,and H(6),q], 3.41 [d, IH, H(2)ax, J= 12.8 water (125 m~). Combined extract~ (ether, 4X50 mL) 
Hz], 3.89 [d, lH, H(2),q, J = 13.4 Hz), 4.98 [d, 1H, of the suspension were washed with 10% NaOH (50 
H(8).,
9
, J = 13.1 Hz], 7.38-7.44 [m, SH, Ar-H]; 13C mL) and saturated NaCl (50 mL), dried (Na2SO4, I h), 
NMR (DCC13) ppm 26.53 [C(l)], 26.87 [C(S)], 31.73 filtered, and concentrated (rotary evaporator then vac-
[C(2)), 31.78 (C(9)), 32.34 [C(4)], 46.07 (C(8)], 52.12 65 uum pump, overnight, RT/0.2 mm Hg) to a yellow oil 
[C(6)), 126.46, 128.41, 128.83, 137.35 (Ar-C), 170.38 (5.53 g, 97.3%). Analysis of the very slight crude amine 
[C=<>]. Anal. Calcd. for C 14H11NOS: C, 67.98; H, 6.93. (30) showed no carbonyl stretch in the IR spectrum, 





an additional 2.75 h at RT. After the addition of H2O 
(30 mL). the organic layer was separated. Additional 
7-Benzyl-3-isopropyl-3,7-diazabicyclo[3.3.l)nonane extracts (CH2Cl2, 3X25 mL) were combined with the 
Hydroperchlorate (5) initial organic layer, dried (Na2SO4, 1 h). filtered, and 
A 125-mL Erlenmeyer flask was equipped with a 5 concentrated (aspirator followed by vacuum pump. I h. 
magnetic stirrer and an ice bath. To a stirred, chilled cs• RT /0.2 mm Hg) to give an orange oil. Chromatography 
C.) solution of the amine (30, 0.84 g. 3.25 mmol) in dry of the oil was performed over neutral alumina (200 g. 
ether (50 mL) was added dropwise a solution of HCJO4 2-1 cm X 33 cm) with ethyl acetate as eluant. Fractions 
(60%, 1.08 g, 6.50 mmol) in isopropyl alcohol (3 mL) (Rr-0.70) were combined and concentrated (rotary 
over 20 min. After the mixture was stirred an additional 10 evaporator then vacuum pump, overnight, RT /0.2 mm 
hour, a white powdery material was filtered, and then Hg) to yield 1.52 g (82.4%) of the amide (32) as an oil 
dissolved in CH3OH. Decolorizing with Norit. filter- which was used without further purification. IR (film) 
ing. and concentrating the solution gave a solid that was cm- 1 3085, 3065, 3035 (Ar C-H), 2970, 2925, 2865, 
recrystallized (CH3OH) to give 0.65 g (49.4%) of salt 2805, 2780, 2750 (C-H), 1635 (C=O), 730, 710 (C-H 
(5); mp 152.0°-152.5" C. IR (KBr) cm-• 3050, 3030 (Ar 15 out of plane, mono); 1H NMR (DCCl3) 60.96 (d, 3H, 
C-H), 2970, 2940, 2910, 2810 (C-H), 1090 (Cl-0); CH3, J=6.4 Hz), 1.07 (d, 3H, CH3, J=6.6 Hz), 
1H NMR (DMSO-d6) 61.18 (d, 6H, CH3), 1.62 [d, lH, 1.65-1.78, [m, 3H, H(S) and H(9)), 1.97 [bs, lH, H(l)], 
H(9), J = 12.4 Hz), 1.82 (d, lH, H(9), 1 = 12.7 Hz], 2.14 2.41 [d, IH, H(4)ax, J = 10.3 Hz], 2.50 [d, lH, H(6)ax, 
[bs, 2H, H(l,5)), 2.47 [d, 2H, H(6,8)ax, J = 11.4 Hz], 3.11 1=11.0 Hz], 2.62 [m, lH, CH(CH3)2, J = 6.5 Hz], 2.72 
(m, 4H, H(2,4)ax and H(6,8)eq), 3.32 (d, 2H, H(2,4)eq, 20 (d, lH, H(6)eq, J = 10.6 Hz], 3.04-3.07 [m, 2H, H(2)ax 
J = I 1.8 Hz). 3.47 [h, lH, CH(CH3)2), 3.52 (s, 2H, and H(4)eq], 3.30 [d, lH, H(8)ax, J = 13.2 Hz], 3.74 [d, 
ArCH2),7.30-7.46(m,5H,Ar-H);l3CNMR(DMSO- lH, H(8)eq, 1=12.8 Hz], 4.77 [d, lH, H(2),q, J=13.9 
d6) ppm 16.11 (q, CH3), 27.24 [d, C(l,5)), 29.67 [t, C(9)], Hz]. 7.28-7.41 (m, SH, Ar-H); 13C NMR (DCCl3) ppm 
52.85 [t, C(2,4[, 56.00 (d, CH(CH3)2], 56.85 [t, C(6,8)), 16.30 (CH3), 19.33 (CH3), 29.06 [C(l)], 29.76 [C(5)). 
61.15 (t, ArCH2), 127.65, 128.35, 129.38, 136.35 25 32.29 (C(9)). 46.55 [C(2)), 52.19 [C(4)], 52.62 (C(8)), 
(Ar-C): 15N NMR (DMSO-d6) ppm 50.90 [N(7)], 54.34 [CH(CH3)i), 54.75 [C(6)], 126.75, 128.24, 128.67, 
60.47 [N(3)]. Anal. Calcd for C17H27CIN2O4: C, 56.90; 137.75 (Ar-C), 170.09 (C==O). 
H, 7.58; N, 7.81. Found: C, 56.70; H, 7.45; N, 7.84. 
EXAMPLE IX 
3-lsopropyl-3, 7-diazabicyclo(3.3. l)nonane (31) 
30 
EXAMPLE XI 
3-Benzoyl-7-isopropyl-3, 7-diazabicyclo(3.3.1 }nonane 
Hydroperchlorate (I) 
A 200-mL, three-necked. round-bottomed flask was A 250-mL Erlenmeyer flask was equipped with a 
equipped with a magnetic stirrer, a heating mantle, a magnetic stirrer and an ice bath. To a chilled (5° C.), 
condenser with a N2 inlel, and two glass stoppers. To a 35 stirred solution of the amide (32, .1.52 g, 5.58 mmol) in 
stirred mixture of amine (30) (5.53 g, 21.4 mmol) and ether (60 mL) was added dropwise HCIO4 (60%, 1.17 g, 
10% Pd/C (0.64 g. 30 mg/mmol of amine) in CH3OH 6.98 mmol) over 10 min. Filtration gave salt (1) as a 
(80 mL) was added anhydrous HCO2NH4 (3.37 g, 53.5 white solid which was washed with dry ether (50 mL), 
mmol) in one portion. Stirring the mixture at reflux stirred in hot CH3OH (30 mL), cooled to - to• C. over-
under N2 for 30 min, cooling the new mixture to RT, 40 night, filtered, and dried (vacuum pump, 61" C./0.2 mm 
and filtering through a celite pad was followed by con- Hg, overnight) to afford 1.90 g (91.3%) of pure salt (I); 
centration of the resulting solution to give a viscous oil. mp 226°-227° C. (dee): IR (KBr) cm- 1 3150 (N-H), 
The oil was then dissolved in H2O (80 mL) and the pH 2990, 2960, 2935, 2920, 2885 (C-H), 1635 (C==O), 1100 
was adjusted to ~ 12 by the addition of 10% NaOH. (Cl-O), 740, 710(C-H out of plane, mono): 1H NMR 
Combined extracts (CH2Cl2, 4 x40 ml) of the aqueous 45 [(D3C)2C=O] 61.55 (d, 6H, CH3, J = 6.6 Hz), 1.97 [bd, 
solution were dried, filtered, and concentrated (rotary IH, H(9), J = 13.0 Hz], 2.18 (bd, 1 H, H(9); J = 13.2 Hz], 
evaporator then vacuum pump, JO min, RT/0.2 mm 2.51 [bs, 2H, H(l,5)], 3.30 [bd, 2H, H(2,4)ax, 1=13.2 
Hg) to give amine (31) as a light oil (3.35 g, 93.0%) Hz], 3.65 [m, 2H, H(6,8)ax], 3.83 [h, lH, -CH(CH3)2, 
which was used without further purification. IR (film) .1 = 6.8 Hz], 3.94 [bd, 2H, H(2,4)eq, 1 = 12.3 Hz], 4.23 [bd, 
cm- 1 3315 (N-H), 2965, 2900, 2850, 2790, 2760, 2725 50 2H, H(6,8)eq, 1=13.2 Hz], 7.45-7.50 (m, SH, Ar-H), 
(C-H); 1H NMR (DCCl3) 61.01 (d, 6H, CH3, J=6.7 7.85(bs, IH,N-H); 13CNMR(DMSO-d6,80"C.)ppm 
Hz), 1.60-1.67 [m, 3H, H(l,S) and H(9)), 2.53-2.59 [m, 16.34 (CH3), 26.69 [C(l,5)), 27.62 [C(9)], 48.80 [C(2,4)], 
3H, ring protons and CH(CH3)2), 2.90-3.06 [m, 6H, ring 52.31 (C(6,8)), 59.91 [CH(CH3)2), 127.05, 128.30, 129.40, 
protons], 3.56 (bs, IH, N-H); 13C NMR (DCCh) ppm 136.40 (Ar-C), 172.86 (C=O). Anal. Calcd. for 
18.12 (CH3), 30.04 [C(l,5)], 33.62 [C(9)], 52.86 [C(6,8)), 55 C11H2sCIN2Os: C, 54.76; H, 6.76. Found: C, 54.43; H, 
54.59 [CH(CH3)2], 54.65 [C(2,4)). 6.78. 
EXAMPLEX 
3-Benzoy]-7-isopropyl-3, 7-diazabicyclo(3.3. l]nonane 
(32) 60 
A three-necked, SO-mL, round-bottomed flask was 
equipped with a magnetic stirrer, an ice bath, a standard 
condenser with a N2 inlet, and two glass stoppers. To a 
solution of 10% NaOH (8.94 g, 22.3 mmol) was added 
the amine (31, 1.14 g, 6.77 mmol) in CH2Cl2 (15 mL) in 65 
one portion. Dropwise addition of a solution of benzoyl 
chloride (1.05 g, 7.45 mmol) in CH2C'2 (5 mL) to the 
mixture over 15 min under N2 was followed by stirring 
EXAMPLE XII 
3-(3' ,4' -Dimethoxybenzyl)-7-isopropyl-3, 7-diazabicy-
clo(3.3. l]nonan-9-one (23) 
A 200.mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a heating mantle, a 
standard condenser with a N2 inlet, a SO-mL addition 
funnel, and a glass stopper. A mixture containing 3,4-
dimethoxybenzylamine (8.36 g, 50 mmol), paraformal-
dehyde (3.15 g. 105 mmol) and CH3OH (35 mL) was 
made acidic with the addition of glacial acetic acid (3.0 




was followed by the dropwise addition of l-isopropyl-4-
piperidinone (42, 7.06 g, 50 mmol) and glacial acetic 
acid (3.0 g. SO mmol) in CH3OH (25 mL) over 1.25 h. 
Boiling of the mixture was continuous for an additional 
23 h. This new mixture was evaporated to give a red s 
viscous oil. After dissolving the oil in H2O (100 mL), 
the solution was extracted (ether, 2 X 100 mL), the latter 
being discarded. Chilling (ice water bath) of the water 
layer below 10• C., followed by basification (pH~ 12) 
d6) ppm 16.25 (CH3), 27.23 [C(l,5)]. 29.79 (C(9)), 52.74 
[C(2,4)], 55.31, 55.36 (OCH3), 55.78 [CH(CH3)2], 56.85 
(C(6,8)]. 60.89 (ArCH2), t 11.23, 113.01, 122.02, 128.00, 
148.38, 148.66 (Ar-C); 15N NMR (DMSO-d1,) ppm 
52.22 [N(7)]. 59.43 [N(3)). Anal. Calcd. for 
C19H31CIN2O6: C, 54.48; H, 7.46. Found: C, 54.76; H, 
7.61. 
EXAMPLE XIV 
with KOH pellets (6.6 g, 100 mmol), produced an 10 7-(4'-Chlorobenzyl)-3-isopropyl-3,7-diazabicyclo(3.3. l-
orange suspension which was extracted (CH2Cl2, 4 X 80 ]nonan-9-one (22) 
mL). Combined extracts were dried (Na2SO4, over-
night), filtered, and concentrated to give a crude oil. 
This oil was digested in 250 mL of Skelly B (bp 60°-68° 
C.) for O.S hand the supernatant was decanted. Evapo- 15 
ration of the solvent gave an oil which, when distilled 
(175•-205• C./t0-4 mm Hg), afforded a yellow oil. 
Adding Skelly B induced crystallization to give 4.32 g 
(26%) of off white ketone (23); mp 79.5"-80.5" C. IR 
(KBr) cm- 1 3095, 3015 (Ar-H), 2980, 2955, 2920, 20 
2855, 2810 (C-H), 1745 (C=O), 1620, 1605 (C=C); 1H 
NMR (DCCl3) 61.03 (d, 6H, CH3, J=6.6 Hz), 2.59 (bs, 
2H, H(l,5)), 2.81-2.90 [m, 5H, ring protons and 
CH(CH3)2], 2.98 (dd, 2H, ring protons, J = 10.7 Hz, 
A 200-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a heating mantle, a 
standard condenser with a N2 inlet, a 50-mL, an addi-
tion funnel and a glass stopper. A mixture of 4-
chlorobenzylamine (7.08 g, 50 mmol), paraformalde-
hyde (3.15 g, lOS mmol), glacial acetic acid (3.0 g, SO 
mmol), and CH3OH (3S mL) was brought to gentle 
reflux with stirring under N2 for I 5 min. To the mixture 
was added dropwise a solution of 1-isopropyl-4-
piperidinone (42, 7.06 g, 50 mmol) and glacial acetic 
acid (3.0 g, SO mmol) in CH3OH (25 mL) over t h. 
Boiling of the mixture was continued for an additional 
24 h. After concentrating to a viscous red oil, the reac-
tion mixture was then diluted with H2O (100 mL) and 
extracted (ether, 3 x 100 mL), the latter being discarded. 
Chilling (via ice water bath) of the aqueous layer to 
below 10• C. was followed by basification (pH~ 13) 
J' = 3.2 Hz), 3.08 (dd, 2H, ring protons, J = 10.7 Hz, 25 
J'=2.99 Hz), 3.47 (s, 2H, ArCH2), 3.87 (s, 3H, OCH3), 
3.88 (s, 3H, OCH3), 6.80-6.92 (m, 3H, Ar-H); 13C 
NMR (DCCl3) ppm 18.17 (CH3), 46.85 [C(l,5)]. 53.40 
[CH(CH3h], 53.86 [C(2,4)). 55.76, 55.86 (OCH3), 58.01 
[C(6,8)], 60.93 (ArCH2), 110.60. 111.46, 120.68, 131.30, 
148.04, 148.90 (Ar-C), 215.27 (C=O); 15N NMR 
(DCCl3) ppm 39.66 [N(7)]. 40.93 (N(3)]. Anal. Calcd. 
for C1qH2sN2O3: C, 68.65; H, 8.49. Found: C, 68.70; H, 
30 with KOH pellets (85%, 6.6 g, 100 mmol). Combined 
extracts (ether, 3 X 60 mL) were dried (Na2SO4, 4 h), 
filtered, and concentrated to give a viscous red oil. This 
oil was digested in pentane (100 mL) for 20 min and the 
supernatant was decanted and concentrated Distillation 8.53. 
EXAMPLE xm 
7-(3' ,4' -Dimethoxybenzyl)-3-isopropyl-3, 7-diazabicy-
clo[3.3.1 Jnonane Hydroperchlorate (7) 
35 of the resulting oil (195° -205" c.110-s mm Hg) gave 
5.25 g of a yellow oil which solidified upon standing. 
Recrystallization (pentane) of the solid gave 3.46 g 
(22.6%) of white crystalline (22); mp 68• -69° C. IR 
To a mixture of KOH pellets (85%, 2.38 g, 36 mmol) 
and the ketone (23, 1.0 g. 3 mmol) in triethylene glycol 40 
(25 mL) was added hydrazine (95%, 1.01 g, 30 mmol) in 
one portion in a 70-mL, jacketed flask equipped with a 
magnetic stirrer, a heating mantle, a standard con-
denser. a lower take-off condenser and two glass stop-
pers. A heating temperature of tso•-160• C. for 3.S h 45 
was achieved by using tetralin (bp 207° C.) in the jacket. 
After cooling to RT, the solution was diluted with cold· 
H2O (SO mL) and extracted with ether (3 X 40 mL). 
Combined extracts were washed with 10% NaOH (50 
mL) and saturated NaCl (SO mL), dried (Na2SO4, over- 50 
night), filtered, and concentrated to afford a yellow oil 
(0.78 g). Dissolution of the oil in ether (SO mL) with 
magnetic stirring and cooling (5" C., via ice water bath) 
in a 125-mL Erlenmeyer flask (equipped with an exter-
nal ice bath) was followed by the dropwise addition of SS 
a solution of HCIO4 (60%, 0.51 g, 3.06 mmol) over 10 
min. Filtering the precipitate, washing the latter with 
ether ( ~ 50 mL), and then recrystallizing (95% EtOH) 
gave 0.79 g (62.9%) of white salt (3); mp 127.5°-128.0" 
C. (dee). IR (KBr) cm-I 3020 (Ar C-H), 29SS, 2930, 60 
2840, 2815, 2790 (C-H), 1610 (C=C), 1090 (Cl-0); 
1H NMR (DMSO-d6) 61.IS (d, 6H, CH3, J=6.7 Hz), 
1.64 [d, lH, H(9), J= 12.1 Hz], t.80 [d, lH, H(9), J = 13.0 
Hz), 2.14 [bs, 2H, H(l,S)), 2.50 [d, 2H, H(6,8)ax, J = 10.4 
Hz], 3.05-3.14 [m, 4H, H(6,8),9 and H(2,4)ax], 3.28 [d, 65 
2H, H(2,4)eq, J = 11.6 Hz], 3.39 [m, tH, CH(CH3), 
J=6.7 Hz], 3.49 (s, 2H, ArCH2), 3.75, 3.76 (twos, 6H, 
OCH3), 6.86-7.08 (m, 3H, Ar-H); DC NMR (DMSO-
(KBr) cm- 1 3030 (Ar C-H), 2955, 2880, 2800 (C-H), 
1730 (C=O), 800 (C-H out of plane, para); 1H NMR 
(DCCl3) 61.03 (d, 6H, CH3, J =6.3 Hz), 2.58 [bs, 2H, 
H(l,5)], 2.80-3.05 [m, 9H, ring protons and CH(CH3)2), 
7.27 (s, 4H, Ar-H); 13C NMR (DCCIJ) ppm 18.25 
(CH3), 46.85 [C(l,5)), 53.40 [CH(CH3)2], 53.76 [C(2,4)], 
57.92 [C(6,8)), 60.48 (ArCH2), 128.40, 129.95, 132.74, 
B7.21 (Ar-C), 215.04 (C=O); ISN NMR (DCCl3) 
ppm 39.18 [N(3)], 40.31 [N(7)). Anal. Calcd. for 
C17H23ClN2O: C, 66.55; H, 7.56. Found: 66.47; H, 7.52. 
EXAMPLE XV 
7-( 4' -Chlorobenzyl)-3-isopropyl-3, 7-diazabicyclo(3.3. l-
Jnonane Hydroperchlorate (6) 
To a mixture of KOH pellets (85%, 1.72 g, 26.1 
mmol) and the ketone (22, 1.0 g, 3.26 mmol) in triethyl-
ene glycol (30 mL) was added hydrazine (95%, 0.44 g, 
13.0 mmol) in one portion in a 150-mL, jacketed flask 
equipped with a magnetic stirrer, a heating mantle, a 
standard condenser, a lower take-off condenser with a 
N2 inlet, and three glass stoppers. A heating tempera-
ture of 200• -210" C. for 4 h under N2 was produced by 
boiling tetralin (bp 207" C.) in the jacket. Cooling of the 
solution to RT was followed by the addition of chilled 
water (40 mL). Combined extracts of the resulting sus-
pension (ether, 4X30 mL) were washed with 10% 
NaOH (30 mL) and saturated NaCl (30 mL), dried 
(Na2SO4, 4 h), filtered and concentrated to a light yel-




spectrum and was used without further purification. lonate (45, 37 g, 0.17 mo)), and hydrobromic acid (48o/c, 
Dissolution of the oil in ether (60 mL) at -5• C. (via ice 280 mL, 2.5 mol). The resulting homogeneous solution 
water bath) was followed by the dropwise addition of a was distilled for 2.5 h (35°-126° C.). and 100 mL of 
solution of HCIO4 (60o/c, 0.68 g, 4.08 mmol) in distillate was collected. Heating was momentarily 
(H3C)2CHOH ( I mL) over 5 min. The resulting. precip- 5 stopped, and the distillation head, condenser and re-
itated solid was filtered and recrystallized (95% EtOH) ceiver were removed and replaced with a condenser. 
to give 0.81 g (63.3%) of white crystals of (6); mp The mixture was heated at reflux for 6 h. A brown 
140°-14t• C. IR (KBr) cm-l 3060, 3020 (Ar C-H), reaction mixture was poured into a 250 mL Erlenmeyer 
2970, 2920, 2830 (C-H), 1485 (C=C), !085 (Cl-O), flask which was allowed to cool to RT (I h) and then 
790 (C-H out of plane, para); •H NMR (DMSO-d6) 10 was placed in an ice bath (1 h) to yield acid (46) as a 
81.19 (d, 6H, CH3, J= 6-7 Hz), l.6! (d, IH, H(9), white solid. This white solid was filtered off using a 
J = 12. 7 Hz), 1-82 [d, 1 H, H(9), J = 12·2 Hz], 2· 14 [bs, 2H, Buchner funnel under suction (aspirator) and was then 
H(l ,5)]. 2.4 I [bd, 2H, H(6,8)ax, J = 11.2 Hz], 3.04 [bd, h d · h Id H O (50 L) " d f d · 
2H H 6 8 J H ] [ was e wit co 2 m to a, ,or , a ter rymg , ( , )eq, =II.I z, 3.16 bd, 2H, H(2,4)ax, 
7 
• H p 0 
J 11 2 H ] 3 [ 2H ] (Abderhalden, 8 C., 12 h/0.2 mm g, 2 5), acid = . z, .34 bd, , H(2,4)eq, J=ll.7 Hz, 15 
3.44-3.52 [m, 3H, CH(CH3)2 and ArCH2], 7.44 [s, 4H, (19.1 g, 46.3%); mp 96°-97° C. The mother liquor was 
Ar-HJ: 13C NMR (DMSO-d6) ppm 16.10 (CHJ), 27.25 concentrated to about 75 mL and then c?<>led to RT 
[C(l,5)], 29.60 (C(9)), 52.77 [C(2,4)], 56.25 [CH(CHJh], (0.5 h) [followed by an ice bath (0.5 h)) to yield a second 
56.75 [C(6,8)), 60.42 (ArCH2), 128.28, 131.27, 132.14, crop of the acid (46) (3.7 g, 9.0%); mp 95•_97• C. IR 
135.72 (Ar-C); 15N NMR (DMSO-d6) ppm 50.34 20 
(KBr)cm- 13500-2500(CO2H),1700(C=0); 1HNMR 
[N(7)), 60.57 [N(3)). Anal. Calcd. for c 17H2oCJ2N2O4: (DCCl3) 63.27 (m, lH, CH), 3.79 (m, 4H, CH2Br), 10.91 
C, 51.92; H, 6.66. Found: C, 51.74; H, 6.57. (bs, IH, CO2H); 13C NMR (DCCI)) ppm 29.80 (t, 
CH2Br), 48.38 (d, CH), 175.30 (s. CO2H). 
EXAMPLE XVI 
3-(4' -Chlorobenzoyl)· 7-isopropyl-3, 7-diazabicy-
clo[3.3. l]nonane (33) 
25 
EXAMPLE XVIII 
Ethyl ,B,,8'-Dibromoisobutyrate (47) 
A 25-mL, three-necked, round-bottomed flask was Into a 250-mL, single necked, round-bottomed flask 
equipped with a magnetic stirrer, a standard condenser equipped with a soxhlet extractor, standard condenser, 
with a N2 inlet, a 10-mL addition funnel and two glass magnetic stirrer and heating mantle were placed the 
stoppers. To a mixture of the amine (31, 0.60 g, 3.57 30 dibromo acid (46, 27 g, 0.11 mo)), benzene (125 mL), 
mmol) in CH2Cl2 (5 mL) and IO% NaOH (3.58 g, 8.93 absolute ethanol (50 mL) and cone H2SO4 (0.5 mL). 
mmol) was added dropwise a solution of 4-chlorobenz- Into the Soxhlet extractor was placed a thimble contain-
oyl chloride (0.69 g. 3.92 mmol) in CH2Cl2 (5 mL) over ing anhydrous MgSO4 (20 g). The reaction mixture was 
15 min. Stirring of the mixture was continued for an heated at reflux for 24 h. Solvent was distilled off until 
additional 3 h under N2. An aqueous mixture, formed 35 about 50 mL remained. The concentrated reaction mix-
upon addition of H2O (30 mL), was extracted (CH2Cl2, ture was cooled to RT (0.5 h), and H2O (50 mL) was 
4 X 25 mL). Combined extracts were dried (Na2SO4, 2 added followed by slow addition of solid NaHCO3 with 
h~. filtered, and concentrated _to give a viscous yellow stirring until the pH was 7. The resulting suspension 
oil. Chromatography of the oil was performed by add- was transferred to a separatory funnel and the organic 
ing an ether solution of the oil to a neutral alumina 40 layer was separated. The aqueous layer was extracted 
column (69 g, 1.7 cm X 30 cm) and th_en u5mg 60:40 with ether (3 X 50 mL). The organic layers were com-
hexanes/ethyl acetate as eluant. Fractions (Rp0.41) bined and washed with HiO (50 mL) and saturated 
were saved and con~entrated (rotary evaporat?r then NaCl (50 mL). This was followed by drying (anhydrous 
vacuum pump, overn~ght, ~T /0.2 mm Hg).'o g!ve 0.86 MgSO4, 2 h), filtration, and evaporation (rotary evapo-
g (80.4%) of off-white sohd (33); mp 97 -98 C. IR 45 · ) · Id I b 1· ·d h' h 
(KBr) cm- I 3085, 3070 (Ar C-H), 2965, 2935, 2865, r~t~r, aspirator to y1e a pa e row? 1qu1 w 1c was 
2800 2170 (C-H) 1630 (C=O)· IH NMR (DCCI ) d1sttlled under reduced pressure to yield the ester (47,.3 ' ' · 3 g, 94. 9% ), bp 60° -62° C./0.2 mm Hg. IR (film) cm - I 
60.95 (d;, 3H, CH3, J =6.5 Hz), 1.05 (d, 3H, CH3, J =6.4 1735 (C=O); IH NMR (DCCIJ) 61.30 (t, 3H, CHJ), 
Hz), 1.63-1.75 [m, 3H, H(5) and H(9)], 1.97 [bs, lH, 3 20 H CH) 3 78 ( 4H CH B ) 4 25 ( 2H H(I)], 2.41 [bd, IH, H(4)ax, J = 10.6 Hz), 2.50 [bd, JH, 50 · (m, l , • · m, • 2 r • · q, • 
H(6)ax, J = 11.2H], 2.59 [heptet, lH, CH(CHJ)2, J =6.5 OCH2); 13C NMR (DCCh) ppm 14.18 (q, CH3), 30.75 
Hz], 2.71 [bd, IH, H(6)eq, J= 1 t.0 Hz), 3.03-3.06 [m, 2H, ~0c;2Br}, 48.52 (d, CH), 61.66 (t, OCH2), 169.32 (s, H(2)ax and H(4)eq), 3.31 [bd, lH, H(8)ax, J= 12.8 Hz], 2 t). 
3.71 [bd, IH, H(8)eq, 13.l Hz], 4.77 [bd, IH, H(2)eq, 
J=l3.2 Hz], 7.27-7.37 (m, 4H, Ar-H); 13C NMR 55 
(DCCI)) ppm 16.37, 19.35 (CH3), 29.07 [C(I)], 29.07 
[C(l)), 29.80 [C(5)], 32.29 [C(9)), 46.68 [C(2)], 52.22 
[C(4)), 52.56 [C(8)], 54.38 [CH(CH3)2), 54.79 [C(6)], 
128.35, 128.51, 134.67, 136.11 (Ar-C), 169.03 (C=O). 
Anal. Calcd. for C11H23CIN2O: C, 66.55; H, 7.56. 60 
Found: C, 66.45; H, 7.71. 
EXAMPLE XVII 
,6,,6'-Dibromoisobutyric Acid (46) 
Into a 500-mL, single necked, round-bottomed flask 65 
equipped with a heating mantle, a magnetic stirrer, a 
Claisen distillation head, a standard condenser and a 





As the starting point for the preparation of (20), the 
preparation of 1-benzyl-4-pyrrolidinyl-1,2,3,6-tetrahy-
dropyridine was required. Into a 250-mL, single-
necked, round-bottomed flask equipped with a Dean-
Stark trap, standard condenser, magnetic stirrer, heat• 
ing mantle, and a N2 inlet were placed t-benzyl-4-
piperidinone (43, 10.2 g, 55 mmol), benzene (125 mL) 
and pyrrolidine (6.0 g, 85 mmol). The resulting mixture 
was heated at reflux for 24 h. The Dean-Stark trap was 
removed and a simple distillation apparatus was in-
. 5,110,933 
15 
stalled. Disrillation of the solvent was completed at 
atmospheric pressure followed by another distillation 
under reduced pressure 10 yield the enamine as a pale 
yellow oil (12.7 g. 97.0%), bp 167°-169' C./0.2 mm Hg. 
IR (film) cm- I 1650 (C=C-N); IH NMR (DCCl3) 5 
61.79 [bs. 4H. H(9,JO)], 2.30 [bs, 2H, H(3)]. 2.56 [t, 2H, 
H(2)]. 3.00 [b!>, 2H. H(8,J J)]. 3.05 [bs, 2H. H(6)]. 3.54 (s. 
2H, CH2Ph), 4. 16 [bs, lH, H(5)], 7.26-7.33 (m, 5H, 
Ar-H); 13C NMR (DCCl3) ppm 24.69 [t, C(9, 10)], 
28.31 [t, C(3)], 47.JO [t, C(8,ll)], 50.07 [t, C(2)], 52.94 [t, JO 
C(6)], 62.68 (t, CH2Ph), 90.24 [d, C(5)], 126.64, 127.88, 
128.92, 138.61 (Ar-C), 141.29 [s, C(4)]. 
Into a 250-mL, three-necked, round-bottomed flask 
equipped with a heating mantle, magnetic stirrer, stan-
dard condenser, dropping funnel and a N2 inlet were IS 
placed a solution of the above enamine [9.9 g, 40 mmol 
in CH3CN (50 mL)] and triethylamine (11.6 g, 9.1 g, 90 
mmol). The resulting mixture was heated at reflux, and, 
to the boiling solution was added dropwise a solution of 
the dibromo ester (47, 11.1 g, 40 mmol) in CH3CN (20 20 
mL) over a period of0.5 h. During addition, triethylam-
monium bromide precipitated as a white solid, and the 
reaction mixture turned brown. Heating was continued 
for 3.5 h after the addition was complete. Solvent was 
removed (rotary evaporator) to yield a dark brown oil 25 
16 
yield the crude thioketal (38) as a pale yellow, viscous 
oil, which was purified by column chromatography 
over silica gel (105 g) using JO% EtOAc in hexanes as 
the eluant. The thioketal was obtained as a colorless oil 
which crystallized out as a white solid upon standing at 
RT (12 h). This white solid was recrystallized (hexanes) 
to yield solid thioketal (38) as white needles (1.6 g. 
42.0'il:, mp 76°-78° C.). IR (KBr) cm- 1 1715 (CO2Et); 
1H NMR (DCCl3) 61.30 (t, 3H, CH3), 1.90 [bs, 2H, 
H(],5)), 2.34 [bd. 2H, H(6,8)0_.], 2.47 [m, IH, H(7)). 
2.68-2.83 [m, 6H, H(6,8).,q, H(2.4)ax and H(2,4)eq), 
3.10-3.17 (m, 4H, SCH2), 3.44 (s, 2H. CH2Ph), 4.19 (q. 
2H, OCH2), 7.12-7.33 (m, SH, Ar-H); 13C NMR 
(DCCIJ) ppm 14.36 (q, CH3), 30.25 [t, C(6,8)], 36.71 [d, 
C(7)], 38.21, 38.64 (t, SCH2), 42.JO [d, C(l,5)], 54.92 [t, 
C(2,4)], 60. 14 (t, CH2Ph), 60.27 (t, OCH2), 127.00, 
127.84, 129.91, 134.21 (Ar-C), 172.35 (CO2Et). Anal. 
Calcd. for C20H21NO2S2: C, 63.66; H, 7.16; S, 16.97. 
Found: C, 63.99; H, 7.08; S, 17.23. 
EXAMPLEXXI 
Ethyl 
3-Benzyl-9, 9-( I, 3-dit hiolan-2-yl)-3-azabicyclo(3.3. I ]no-
nane-7-( endo )-carbox y late Hydroperchlorate (14) 
to which was added H2O (50 mL). The mixture was Into a 250-mL Erlenmeyer flask equipped with a 
e,macted with HCCl3 (4 X SO mL). The organic layers magnetic stirrer were placed the thioketal (38, l.5 g, 4 
were combined and washed successively with HCI (IN, mmol), anhydrous ether (ISO mL), and absolute ethanol 
2 X SO mL), NaHCO3 (saturated aqueous, 2_ X SO mL) (5 mL). The resulting solution was cooled in an ice bath 
and NaCl (saturated, 2 X 50 mL). After drymg (anhy- JO for 0.5 h. To this cooled solution was added dropwise 
drous Na2SO4), the solution. was filtered and evapo- HCIO4 (60%, 0.85 g, 5 mmol) over a period of 0.5 h. 
rated (rotary evaporator) to yield the ~rude ket~ne (20) During the addition a white solid precipitated. The 
as a dark brown 011. This dark bro~n 011 was punfied by resulting mixture was stirred in an ice bath for another 
column chromotography. over sthca gel. (ISO g. 3.8 J h, after the addition was complete, and then for 2 hat 
cm X61 cm: 1 '!IL/mm) usmg JOiie EtOAc m hexa_nes as 35 RT. The white solid obtained by filtration was recrys-
t~e eluant to yield ketone (2~) as a pale yellow, viscous tallized (isopro yl alcohol) to yield the thioketal hy-
011 (4.1 g, 33.09c). R_r=0.49 m 9:1 hexanes:EtOAc. IR p . 
(fil ) - t 1730 (C=O)· IH NMR (DCCI ) 61 30 ( droperchlorate (14) as white needles (1.7 g, 90.0%); mp tm cm - · 3 · t, J53"-154°C.IR(KBr)cm-13400(N-H),1700(CO-
3H,CH3),2.18(dd,2H,H(6,8)ax,J=6.9, IS.9Hz),2.29 E) JIOO (Cl-O)· IH NMR (DCCI) 6130 ( 3H 
[bs, 2H, H(l,5)], 2.~ [m, 3H. H(6,8),q and H(7),xo), 2.82 40 ~~;), 2_05 [d, 2H, H(6,8)ax, J = 16. J H~). 2.36 [b~, 2H: 
[dd, 2H. H(2.4),u, J-6.0, 14.4 Hz], 3.04 [d, 2H, H(2,4),q, H(l S)] 2 7l [ 2H H(6 8) ) 3 33 ( 4H SCH ) 3 SO J = l0.6 Hz], 3.56 (s, 2H. CH2Ph), 4.22 (q. 2H, OCH2), • • · m, • • ,q • · m, • 2 • · 
7. 17-7.30 (m, 5H, Ar-H): t3C NMR (DCCIJ) ppm [m, 2H, H(2,4)ax], 3.68 (d, 2H, CH2Ph), 7.43-7.60 (m, 
14.35 (q, CH 3), 33.21 [t. C(6,8)], 37.75 [d, C(7)], 46.61 [d, SH, Ar-H), 10.30 (bs, lH, N-H); 
13C NMR (DCCl3) 
C(J,5)], 58.06 (I, CH2Ph), 60.34 (t, OCHi), 127.26, 45 
ppm 13.79 (q, CH3), 28.42 [t, C(6,8)), 29.53 [d, C(7)), 
128.09, 129.50, 135. JO (Ar-C), 172.40 (s, COiEt), 39. 18 [d, C(J,5)], 39.51, 39.88 (t, SCH2), 56.60 [t, C(2,4)]. 
215.92 (C=<>). The oil, very slightly crude (20), was 61.81 (t, CH2Ph), 63.67 (t, OCH2), 68.96 [s, C(9)], 
used without further purification for succeeding steps 127.84, 129.93, 130.31, 131.57 (Ar-C), 183.05 (s, CO-
since the oil decomposed upon attempted distillation. 2Et). Anal. Calcd. for C2oH2sCINO0S2: C, 50.26; H, 
EXAMPLE XX 
Ethyl 
3-Benzyl-9, 9-( J ,3-dithiolan-2-yl)-3-azabicyclo[3. 3.1 )no-
nane-7-(endo )-carboxylate (38) 
so 
Into a 100-mL, three-necked, round-bottomed flask 55 
equipped with a magnetic stirrer, standard condenser, 
dropping funnel, N2 inlet and an ice-bath were placed 
the ketone (20, 3.01 g, 10 mmol), 1,2-ethanedithiol (2 
mL, 2.25 g. 24 mmol), and dr)' HCC!) (50 mL). The 
resulting mixture was cooled to o• -s• C. in an ice bath. 60 
Freshly distilled BF3 etherate (4 mL, 2.2 g, JS mmol) 
was added dropwise over a period ofO.S h. The reaction 
mixture was stirred at o• -5• C. for 1 h and then at RT 
for 8 h. To the resulting mixture was added HCCh (25 
mL), and the solution was successively washed with 65 
NaOH (IN, 3XS0 mL) and NaCl (saturated, 50 mL). 
After drying (anhydrous Na2SO4), the solution was 
filtered and evaporated (rotary evaporator, aspirator) to 
5.86; N, 2.93. Found: C, 50.24; H, 6.12; N, 2.94. 
EXAMPLEXXII 
Ethyl 
3-Benzyl-3-azabicyclo[3.3. l ]nonane-7-(endo )-carboxy-
late Hydroperchlorate (13) 
Ester (38) (1.89 g, 0.005 mo]), ethanol (200 mL), and 
Raney nickel (about 20 mL of a wet solid) were heated 
together at reflux for J 8 hours, and the mixture was 
allowed to cool. After the mixture was filtered, the 
solvent was evaporated to a viscous oil. The oil was 
treated with a saturated brine solution, and the resulting 
mixture was extracted with chloroform (3 X 50 mL). 
Evaporation of the solvent gave a colorless oil (0.97 g. 
68.0%). Thus, slightly crude ethyl 3-benzyl-3-azabicy-
clo[3.3.1Jnonane-7-(endo)-carboxylate was used in the 
next step without further purification. 
Into a 250 mL Erlenmeyer flask equipped with mag-




mmol), anhydrous ether (150 mL), and absolute ethanol mmol) in CH2Cl2 (5 mL) and !Oo/c NaOH (3.58 g, 8.93 
(5 mL). The resulting solution was cooled in ice bath mmol) was added dropwise a solution of 3,4-dimethoxy-
and to the chilled solution was added dropwise HCIO4 benzoyl chloride (0.80 g, 3.92 mmol) in CH2Cl2 ( 10 mL) 
(60%, 0. 75 g, 4.5 mmol) over a period of 0.5 h. During over 15 min. Stirring of the mixture was continued for 
the addition, a white solid precipitated. The resulting 5 an additional 3 h under N2. An aqueous mixture, formed 
mixture was stirred in ice bath for I h, after the addition upon addition of H2O (30 mL), was extracted (CH2Cl2, 
was complete, and then for 2 hat RT. Filtration and 4X25 mL). Combined extracts were dried (Na2SO4, 2 
recrystallization (isopropyl alcohol) yielded the hy- h), filtered and concentrated to give a viscous yellow 
droperchlorate (13) as colorless platelets (0.87 g. oil. Chromatography of the oil was performed on neu-
68.0're ); mp 130° -131 • C. IR (KBr) cm- 1 3440 (N-H), 10 tral alumina (74 g, I. 7 cm x 32 cm) using 60:40 ethyl 
1700 (CO2Et), 1100 (Cl-O); 1H NMR (DCCJ3) 61.30 acetate/hexanes as eluant. Fractions (Rp0.31) were 
(t, 3H, CH3), 1.61 [bd, lH, H(9)endo], 1.87 [d, 2H, saved and concentrated (rotary evaporator then vac-
H(6,8)0,., J=12 Hz), 2.05 [bd, lH, H(9)e..o], 2.16-2.31 uum pump, overnight, RT/0.2 mm Hg) to give 0.87 g 
[m, 4H, H(l,5) and H(6,8)eq), 2.91-2.98 [m, IH, H(7)), (73.1%) of off-white solid (34); mp 67.5°-69.5° C. JR 
3.35-3.48 [m, 4H, H(2,4)ax and H(2,4)eq], 4.32 (q, 2H, 15 (KBr) cm- I 3055 (Ar C-H). 2950, 2915, 2845, 2820, 
OCH2), 4.50 (d, 2H, CH2Ph), 7.38-7.68 (m, SH, 2770, 2750, 27IO (C-H), 1625 (C==O); IH NMR 
Ar-H); 13C NMR (DCCIJ) ppm 13.79 (q, CH3), 25.74 (DCCl3) 60.96 (d, 3H, cH3, J=6.4 Hz), 1.06 (d, 3H, 
[d, C(l,5)], 27.85 [t, C(6,8)), 31.91 [d, C(7)), SS.96 (t, cH3,J=6.SHz), t.62-l.75(m,3H,H(5)andH(9)), 1.96 
C(2,4)], 61.68 (t, CH2Ph), 63.05 (t, OCH2), 128.60, [bs, IH, H(l)], 2.43 [bd, JH, H(4)
0
_., J =9.7 Hz], 2.51 (bd, 
129.98, 131.25, (Ar-C), 182.93 (s, C02Et). Anal. Calcd. 20 lH, H(6)a.x, J = l0.5 Hz], 2.62 [heptet, IH, CH(CH 3)2, 
:~ 
6
~~i~26CIN06: C, 55.75; H, 6.71. Found: C, 56.11; l=6.4 Hz), 2_74 [bd, IH, H(6)eq, J=9.9 Hz], 3.00-3.09 
[m, 2H, H(4)eqand H(2)0,..], 3.32 [bd, IH, H(8)a,. J = 13.2 
Hz), 3.83-3.94 [m, 7H, H(8),q and OCH3), 4.77 [bd, IH, 
H(2),q, l=13.3 Hz], 6.84-6.94 (m, 3H, Ar-H); 13C 
EXAMPLE xxm 
7-lsopropyl-3-(3 ',4' ,5 '-trimethoxybenzoyl)-3, 7-
diazabicyclo(3.3. l]nonane (35) 
25 NMR (DCCl3) ppm 16.46, 19.15 (CH3), 29.13 [C(l)), 
29.86 [C(S)), 32.36 [C(9)), 46.71 [C(2)], 52.25 [C(4)), 
A 25-mL, three-necked, round-bottomed flask was 52.65 (C(8)], 54.35 [CH(CH3)2], 54.68 (C(6)], 55.88, 
equipped with a magnetic stirrer, a standard condenser 55.93 (OCHJ), 110.50, 119.64, 130.23, 148.78, 149.39 
with N2 inlet, a 10-mL addition funnel and two glass (Ar-C), 169.90 (C==O). Anal. Calcd. for C 19H28N2O3: 
stoppers. To a mixture of the amine (31, 0.60 g, 3.57 3° C, 68.65; H, 8.49. Found: c, 68.58; H, 8.47. 
mmol) in CH2Cl2 (5 mL) and 10% NaOH (3.58 g, 8.93 
mmol) was added dropwise a solution of 3,4,5-trime- EXAMPLE XXV 
thoxybenzoyl chloride (0.92 g, 3.92 mmol) in CH2Cl2 (5 
mL) over 15 min. Stirring of the mixture was continued 
for an additional 3 h under N2. An aqueous mixture, 35 
3-(3 ',4' -Dimethoxybenzoy 1)-7-isopropyl-3, 7-diazabicy-
clo(3.3. l]nonane Hydroperchlorate (3) 
upon addition of H2O (30 mL). was extracted (CH2Cl2, A 50-mL Erlenmeyer flask was equipped with a mag-
4 x 25 mL). Combined extracts were dried (Na2SO4, 2 netic stirrer and an ice bath. To a chilled (5° C.), stirred 
h), filtered, and concentrated to give a viscous yellow solution of the amide (34, 0.30 g, 0.90 mmol) in ether (30 
oil. Chromatography of the oil was performed on neu- mL) was added dropwise a solution of HCIO4 (60%, 
tral alumina (74 g, 1.7 cm x 32 cm) using 60:40 ethyl 40 0.18 g, 1.08 mmol) in isopropyl alcohol (1 mL) over 10 
acetate/hexanes as eluant. Fractions (Rp0.34) were min. A white precipitate resulted which was filtered 
saved and concentrated (rotary evaporator then vac- and then stirred in hot CH3OH (IO mL) for 20 min. The 
uum pump, overnight, RT /0.2 mm Hg) to give 1.02 g mixture was filtered and dried (Abderhalden, P2O5, 
(79.1%) of off-white solid (35); mp 67.5°-69.5° C. IR overnight, RT/0.2 mm Hg) to give 0.27 g (69.2%) of 
(KBr) cm-I 3055 (Ar C-H), 2985, 2955, 2910, 2890, 45 white solid (3); mp 235"-236° C. (dee). IR (KBr) cm- 1 
2780 (C-H), 1620 (C==O); 1H NMR (DCCl3) 60.96 (d, 3130 (N-H), 3010 (Ar C-H), 2975, 2945, 2920 
3H, CH3, J = 6.5 Hz), 1.09 (d, 3H, CH3, J =6. 7 Hz), (C-H), 1635 (C==O), 1095 (Cl-O); 1H NMR (DMSO-
1.64-1.79 [m, 3H, H(5) and H(9)), 2.05 [bs, lH, H(I)), do, so• C.) 61.33 (d, 6H, CH3, J=6.7 Hz), 1.74 [bd, lH, 
2.44 [bd, lH, H(4)ax, J = l0.6 Hz], 2.57 [bd, lH, H(6)ax, H(9), J = 12.8 Hz], J.91 [bd, JH, H(9), J = 13.2 Hz], 2.27 
J=I0.8 Hz), 2.66 [heptet, lH, CH(CH3)2, l=6.6 Hz), 50 [bs, 2H, H(l,5)], 3.12 [bd, 2H, H(6,8)a.x, J=l3.7 Hz], 
2.71 [bd, IH, H(6)eq, J = 11.0 Hz), 3.02-3.07 (m, 2H, 3.19-3.28 [m, 2H, H(2,4)ax), 3.42-3.56 [m, 3H, H(6,8)eq 
H(4)rq and H(2)a.x], 3.31 [bd, lH, H(8)a.x, J = 13.2 Hz], and CH(CH3)i], 3.78, 3.81 (twos, 6H, OCH3), 3.97 [bd, 
3.80-3.92 [m, JOH, H(S)rq and OCH3), 4.77 [bd, lH, 2H, H(2,4)eq, J = 13.6 Hz], 6.94-7.03 [m, 3H, Ar-HJ, 
H(2)eq, l= 13.5 Hz], 7.29 (s, 2H, Ar-H); 13c NMR 7.81 (bs, IH, N-H); 13C NMR (DMSO-d6, so· C.)ppm 
(DCCIJ) ppm 15.87, 19.42 (CH3), 29.02 [C(I)), 29.78 55 16.34 (CHJ), 26.81 [C(l,S)), 27.80 [C(9)], 49.06 [C(2,4)], 
(C(5)), 32.3S [C(9)), 46.64 [C(2)], 51.73 [C(4)], s2.48 52.40 [C(6,8)), 55.88, 55.92 (OCH3), 59.97 [CH(CH3)2), 
[C(8)], 54.39 [CH(CH3)2), 54.95 [C(6)), S6. l3, 60-86 111.85, 112.10, 120.44, 128.68, 148.74, 150.26 (Ar-C), 







169.66 (C==O). Anal. Calcd. for C2oH30N204: C, 66.27; 52.72; H, 6.75. Found: C, 52.35; H, 6.77. 
H, 8.34. Found: C, 66.04; H, 8.32. 60 
EXAMPLE XXIV EXAMPLE XXVI 
3-{3' ,4' -Dirnethoxybenzoyl)-7-isopropyl-3, 7-
diazabicyclo( 3. 3. l )nonane (34) 
A 25-mL, three-necked, round-bottomed flask was 65 
equipped with a magnetic stirrer, a standard condenser 
with a N2 inlet, a 10-mL addition funnel, and two glass 
stoppers. To a mixture of the amine (31, 0.60 g, 3.57 
3-Benzenesulfonyl-7-isopropyl-3, 7-diazabicyclo[3.3. l • 
Jnonane (36) 
A 50-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a standard condenser 
with a N2 inlet, an ·ice bath, a 10-mL addition funnel, and 
a glass stopper. To a stirred, ice cold (5° C.) mixture of 
5,110,933 
20 19 
the amine (31, 1.03 g. 6.12 mmol) and NaOH pellets 
(97%. 0.76 g. 18.4 mmol) in H2O (7 mL) and CH2Cl2(5 
mL) was added dropwise a solution of benzenesulfonyl 
chloride (2.16 g. 12.2 mmol) in CH2Cl2(5 mL) over 30 
min. Stirring of the mixture was continued for an addi- 5 
tional 17.5 h at RT. The reaction mixture was then 
partioned between H2O (30 mL) and CH2Cl2(30 mL) 
followed by basilication (pH- 12) of the aqueous phase. 
Extracts (CH2Cl2,3 x 30 mL) of the remaining water 
layer were combined with the initial organic layer. The JO 
solution was washed with 10% NaOH (30mL) and then 
saturated NaCl (30 mL); it was dried (Na2SO4, over-
night), filtered, and concentrated to give an orange 
viscous oil. Chromatography of the oil was performed 
on silica gel (39 g, 1.6 cm X 62 cm) using 10% J 5 
CH3OH/CH2C'2. Fractions (RF0.44) were saved, 
concentrated, and reeluted on neutral alumina (90 g. 2.5 
cmx 18 cm) employing ethyl acetate as eluant. Frac-
tions (RF0.53) were saved and concentrated. A col-
ored impurity persisted which was removed by again 20 
eluting over silica gel (21 g, 1.6 cm X 33 cm) using 5% 
CH3OH/CH2Cli as eluant. Fractions (RF0.34) were 
combined and concentrated (rotary evaporator then 
vacuum pump, overnight, RT /0.2 mm Hg) to give 0.54 
g (28.6%) of white solid (36); mp 85.5'-86.5' C. IR 25 
(KBr) cm- 13060 (Ar C-H), 2960, 2910, 2890, 2865, 
2820 (C-H). 1585 (C=C), 1340, 1170 (S=O), 760, 720 
(C-H out of plane, mono); IH NMR (DMSO-da) 60.88 
(d. 6H, CH.J, J = 6.5 Hz), 1.40 [bs, 2H, H(9)], 1.94 [bs, 
2H. H(l,5)]. 2.35 [bd, 2H, H(6,8)a.,, J = 10.3 Hz]. 2.53 30 
(heptet, IH, CH(CH3h, J=6.5 Hz]. 2.69 (bd, 2H, 
H(6,8),·q• J = 10.3 Hz]. 2.89 [dd, 2H, H(2.4)ax, J = 11.2 
Hz, J' = 4.5 Hz). 3.36 [d. 2H, H(2.4),·q• J = 10.9 Hz], 
7.58-7.75 (m. SH. Ar-H); 13C NMR (DMSO-da) ppm 
17.57 (CH,). 27.39 (C(l.5)]. 28.95 [C(9)]. 48.88 [C(2.4)], 35 
52.66(C(6,8)). 53.42 [CH(CH3h], 126.90, 129.01, 132.36, 
136.79 (Ar-C). Anal. Calcd. for C1aH24N2O2S: C, 
62.31; H, 7.85. Found: C, 62.48; H, 7.69. 
EXAMPLE XXVII 
40 
7-lsopropy 1-3-t hia-7-azabic yclo(3. 3. 1 ]nonan-9-one (26) 
A three-necked, 300-mL, round-bottomed flask was 
equipped with a magnetic stirrer, a heating mantle, a 
standard condenser with a N2 inlet, and two glass stop-
pers. A mixture containing isopropylamine (2.96 g, 50 45 
mmol). paraformaldehyde (12.01 g, 400 mmol), and 
CH;OH(l88 mL) was made acidic with glacial acetic 
acid (4.5 g, 75 mmol). In one portion, 4-thianone (44, 
H(l.5)], 3.05-3.13 (m, 4H. ring protons), 3.24-3.29 (m, 
2H, ring protons): 13C NMR (DCCl3) ppm 18.30 (q. 
CH3). 34.16 [t. C(2.4)). 47.52 [d, C(l,5)], 53. 76 [d, 
CH(CH3h], 54.16 [t. C(6,8)}, 213.68 (s, C=O); 15N 
NMR (DCCl3) ppm 39.27 [N(7)}. Anal. Calcd. for 




To a mixture of KOH pellets (85%, 3.96 g, 60 mmol) 
and the ketone (26, 1.0 g, 5 mmol) in triethylene glycol 
(25 mL) was added hydrazine (95%, 1.69 g, 50 mmol) in 
one portion in a 70 mL, jacketed flask equipped with a 
magnetic stirrer, a heating mantle, a standard con-
denser, a lower take-off condenser with a N2 inlet, and 
two glass stoppers. A heating temperature of 200° -21 o• 
C. for 5 h was produced by boiling tetralin (bp 207° C.) 
in the jacket. After cooling to RT, the solution was 
diluted with chilled water (100 mL) and extracted with 
ether (4X50 mL). Combined extracts were washed 
with 10% NaOH (50 mL) and saturated NaCl (50 mL), 
dried (Na2SO4, overnight), filtered, and concentrated to 
a yellow oil (0.8 g). Dissolution of the oil in ether (50 
mL) via magnetic stirring and cooling (5" C.) with an 
external ice bath was followed by dropwise addition of 
a solution of HCIO4 (60%, 1.08 g, 6.45 mmol) in isopro-
pyl alcohol (3 mL) over 10 min. Stirring of the mixture 
an additional 10 min, filtering the precipitated salt, and 
then washing the latter with ether ( - 50 mL) gave an 
off-white solid. Dissolving the salt in hot 95% EtOH 
and decolorizing the solution with Norit, followed by 
filtering, and cooling, afforded 0.91 g (63.6%) of salt (8) 
as a white solid; mp 281°-282.5' C. IR (KBr) cm- 13060 
(N-H), 3000, 2960, 2935 (C-H), 1090 (Cl-O); IH 
NMR (DMSO-d6) 61.28 (d, 6H, CH3), 1.76 [d, IH, H(9), 
J = 13.3 Hz], 1.91 [d, IH, H(9), J = 12.9 Hz], 2.35 [bs, 2H, 
H( 1,5)], 2. 78 [bd, 2H, H(2,4 )ax, J = 12.2 Hz], 3.14 [bd, 
2H, H(2,4)eq, J = 13.6 Hz], 3.29-3.57 [m, 3H, H(6,8)ax 
and CH(CH3)2], 3.62 [d, 2H, H(6,8)eq, J = 12.7 Hz], 9.07 
(bs, lH, N-H); !3C NMR (DMSO-d6) ppm 16.19 (q, 
CH3), 25.51 [d, C(l,5)], 28.35 [t, C(9)], 30.69 [t, C(2,4)], 
52.36 [t, C(6,8)], 58.66 [d, CH(CH3)2]; 15N NMR 
(DMSO·d6) ppm 58.47 [N(7)]. Anal. Calcd. for 
C10H2oCINO4S: C, 42.03; H, 7.05. Found: C, 42.10; H, 
7.18. 
5.81 g, 50 mmol) was added followed by stirring at EXAMPLE XXIX 
reflux for 21 h. Evaporation of the solvent gave a red SO 7-(3'-Iodobenzyl)-3-thia-7-azabicyclo[3.3. l)nonan-9-one 
oil, which was diluted with H2O (200 mL) and ex- (25) 
tracted with ether (2 X 100 mL), the latter being dis-
carded. Basification (pH~ 12) of the aqueous layer by A 100 mL, three-necked, round-bottomed flask was 
the addition of NaOH pellets (3.0 g, 75 mmol) resulted equipped with a magnetic stirrer, a ·heating mantle, a 
in the formation of a yellow suspension which was 55 standard condenser with a N2 inlet, and two glass stop-
extracted with CH2C)i(4X 100 mL). Combined extracts pers. A mixture containing 3-iodobenzylamine (1.19 g, 
were dried (MgSO4, overnight), filtered, and concen- 5.10 mmol), paraformaldehyde (1.22 g, 40.8 mmol), and 
trated to afford a yellow oil which solidified upon CH3OH (30 mL) was made acidic with glacial acetic 
standing. This solid was digested in 250 mL of Skelly B acid (0.46 g, 7.65 mmol). In one portion, 4-thianone (44, 
(bp 60° -68• C.) for 30 min, and the supernatant was 60 0.59 g, 5.10 mmol) was added and the resulting mixture 
decanted. Evaporation of the solvent, followed by heat- was heated under N2 at reflux for 21 h. Evaporation of 
ing the crude solid in vacuo (95• - l 1 o• C./0. 3 mm Hg) in the solvent gave a reddish oil, which was dissolved in 
a sublimation apparatus gave a sticky white solid (mp H2O (40 mL). Basification (pH~ 13) of the solution by 
54• _57• C.). Recrystallization (Skelly B) afforded 4. 15 g the dropwise addition of 10% NaOH resulted in the 
(41.6%) of white flakes of ketone (26); mp 59°-60° C. IR 65 formation of a milky suspension which was extracted 
(){Br) cm- 12965, 2935, 2900, 2875, 2805 (C-H), 1730 with ether (5 X 40 mL). Combined extracts were dried 
(C=O); IH NMR (DCCl3) 61.04 (d, 6H, CH3, J=6.7 (Na2SO4, overnight), filtered, and concentrated to a 




mmo)) and glacial acetic acid (6.01 g, 100 mmol) in 
CH3OH (100 mL) was then added dropwise over I h 
and this was followed by a period of renux for an addi-
tional 18 h. Upon cooling the mixture to RT, the solvent 
( 125 mL, bp 60° -68° C.) for 30 min, and the supernatant 
was decanted. Funher digestion of the residual material 
was effected in pentane (2 X 125 mL) for 30 min. Com-
bined supernatant extracts were concentrated (rotary 
evaporator the vacuum pump, overnight, RT /0.2 mm 
Hg) to give 0.84 g (57.5%) of a slightly crude viscous oil 
(25) which was used without further purification in the 
next step. JR (film) cm- 13055 (Ar C-H), 2930, 2825 
(C-H), 1735 (C=O), 885,790,695 (C-H out of plane, 
meta); 1H NMR (DCCl3) 62.72-3.18 [m, JOH, ring pro-
tons and H(l,5)), 3.51 (s, 2H, ArCH2), 7.07-7.71 (m, 4H, 
Ar-H): 13C NMR (DCCI)) ppm 35.05 [C(2,4)), 46.95 
[C(),5)], 58.20 [C(6,8)], 60.69 (ArCH2). 94.43, 127.98, 
130.23, 136.44, 137.64, 140.63 (Ar-C), 213.00 (C=O). 
5 was removed and the resulting red oil was redissolved 
in H2O {JOO mL). Combined extracts (ether, 2 X 100 
mL) of the acidic aqueous layer were discarded. Basifi-
q1tion of the chilled (10° C., ice water bath) water layer 
to pH~ 12 was effected by the addition of 10% NaOH. 
10 Combined extracts (ether, 4x60 mL) were dried (Na2. 
S04, I h), filtered, and concentrated to give a viscous 
red oil. This oil was digested (Skelly B, 2 x 250 mL, 20 
min), and the supernatant extracts were concentrated 
and then distilled (190°-215° CJJ0-5 mm Hg) to give 
15 an oil. Crystallization of the oil was induced by dis-
solving the oil in hot pentane (800 mL) and then chilling 
(-10° C.) the solution to give 14.66 g (45.8%) of white, 
crystalline ketone (19); mp 82.5°-83.5° C. Concentra-
EXAMPLEXXX 
7-(3' -Iodobenzyl)-3-thia-7-azabicyclo[3.3. l)nonane 
Hydroperchlorate (9) 
To a mixture of KOH pellets (85%, 0.48 g, 7.2 mmol) 
and the ketone (25, 0.224 g, 0.60 mmol) in triethylene 20 
glycol (10 mL) was added hydrazine (95%, 0.20 g, 6.0 
mmol) in one portion in a 50-mL, jacketed nask 
equipped with a magnetic stirrer, a heating mantle, a 
standard condenser, a lower take-off condenser with a 
tion (hot plate) of the mother liquor to ~ 80 mL pro-
duced a second crop (0.81 g, 2.5%) of 3,7-dibenzyl-3,7-
diazabicyc!o(3.3.t]nonan-9-one (19); mp 81.5°-82.0° C. 
The total yield was (15.47 g, 48.3%). 
A 70-mL, five-necked, jacketed nask was equipped 
with a magnetic stirrer, a heating mantle, a standard 
condenser, a lower take-off condenser with a N2 inlet, a 
thermometer, and two glass stoppers. After the addition 
of the ketone (19, 2.0 g, 6.24 mmol), KOH pellets (85%, 
4.94 g, 56.1 mmol) and hydrazine (95%, 2.11 g, 32.1 
30 mmol) in triethylene glycol (40 mL) were added. The 
apparatus was flushed with N2, and the mixture was 
heated at 140°-150° C. for 4 h using boiling o-xylene (bp 
144° C.) in the jacket. Cooling the solution to RT was 
N2 inlet, and two glass stoppers. A heating temperature 25 
of 140°-150° C. for 4 h was produced by boiling o-
xylene (bp 144° C.) in the jacket. After cooling to RT, 
the solution was diluted with cold H2O (30 mL) and 
was then extracted with ether (4 X 30 mL). Combined 
extracts were washed with 10% NaOH (30 mL) and 
saturated NaCl (30 mL), dried (Na2SO4, overnight), 
filtered, and concentrated 10 give a yellow oil (209 mg). 
Dissolution in ether (25 mL) via magnetic stirring and 
cooling (5° C.) in a 50-mL Erlenmeyer nask equipped 
with an external ice bath was followed by the dropwise 35 
addition of a solution of HCIO4 (60%, 0.15 g, 0.87 
mmol) in isopropyl alcohol {l mL) over 10 min. Filtra-
tion of the precipitate and then washing the latter with 
ether ( ~ 50 mL) gave a solid which changed to an oil. 
This oil was dissolved in 95% EtOH, and the solution 40 
was decolorized with Norit, filtered, and left to stand at 
RT overnight. White crystalline salt (9) was collected 
(77 mg, 27.7%); mp 169.5°-170° C. JR (KBr) cm- 13045 
(Ar C-H), 2950, 2915, 2825 (C-H), J 570 (C=C), 1085 
(Cl-O), 780, 765 (C-H) out of plane, meta); IH NMR 45 
(DMSO-d6) 61.81 [m, 2H, H(9)], 2.36 [bs, 2H, H(l,5)), 
2.70 [d, 2H, H(2,4)ax, J = 13.6 Hz), 3.09 (d, 2H, H(2,4),q, 
followed by the addition of chilled water (80 mL). 
Combined extracts (ether, 3 X 75 111L) of the suspension 
were washed with saturated NaCl (75 mL), dried (Na2. 
SO4, overnight), filtered, and concentrated to a yellow 
oil (J.83 g, 95.7%) which displayed no carbonyl stretch 
in the JR spectrum. This oil, that is amine (37), was used 
without further purification. 
A 100-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a condenser with a N2 
inlet, a 50-mL addition funnel, and a glass stopper. To a 
solution of NaJO4 (2.49 g, J 1.62 mmol) in H2O (22.4 
mL) was added RuO2_XH2O (0.1 g) which produced a 
dark green solution. After the apparatus was flushed 
with N2, a solution of the amine (37, 0.89 g, 2.9 mmol) 
in CCl4 (16 mL) was added in one portion to produce a 
black mixture. The mixture was stirred at RT for 72 h 
50 and then the organic layer was separated. Further ex-
traction of the aqueous phase was effected with CCl4 
(20 mL) followed by HCCl3 (3 X 20 mL). Combined 
extracts were treated with isopropyl alcohol (3 mL) to 
J = 13.7 Hz], 3.35 [m, 2H, H(6,8)a . .J, 3.58 [d, 2H, 
H(6,8),9, J = 11.9 Hz), 4.22 (s, 2H, ArCH2), 4.24 (s, JH, 
ArCH2), 7.32-8.03 (m, 4H, Ar-H), 9.20 (bs, JH, 
N-H); 13C NMR (DMSO-d6) ppm 25.78 (C(l,5)), 
28.48 [C(9)], 30.65, [C(2,4)], 56.53 (C(6,8)], 60.04 
(ArCH2), 95.40, 129.93, 131.08, 132.47, 138.18, 138.93 
(Ar-C); 15N NMR (DMSO-d6) ppm 54.17 [N(7)]. 
Anal. Calcd. for C14H19CIINO4S: C, 36.58; H, 4.17; N, 55 
3.05; I, 27.60. Found: C, 36.87; H, 4.15; N, 2.99; I, 27.64. 
EXAMPLE XXXI 
destroy excess oxidant and were then filtered through a 
celite pad. After washing the extracts with 5% sodium 
thiosulfate (50 mL), the extracts were dried (Na2S04, 
overnight), filtered, and concentrated to a yellow oil. 
Elution of the oil on neutral alumina (84 g, 2.4 cm X J 9 
3,7-Dibenzyl-3,7-diazabicyc1o(3.3. J]nonan-2-one (19) cm) using first ether (50 mL) and then ethyl acetate (150 
A 500-mL, three-necked, round-bottomed flask was 60 mL) as eluants gave a solid material {RJ=0.60, ethyl 
equipped with a magnetic stirrer, a heating mantle, a acetate). This material was recrystallized by dissolving 
standard condenser with a N2 inlet, a 250-mL addition in ether (6 mL) and then refrigerating at - to• C. for 2 
funnel, and a glass stopper. A mixture of benzylamine h; this solution was placed in a diffusion chamber of 
(10.71 g, 100 mmol), HCI (37%, 4.93 g, SO mmol), gla- pentane for I h. Filtration afforded (0.27 g, 28.9%) of 
cial acetic acid (6.0 g, 100 mmol) and paraformaldehyde 65 the Jactam (17); mp 96.0°-96.5° C. JR (KBr) cm- 13070, 
(6.31 g, 210 mmol) in CH3OH (100 mL) was brought to 3050, 3020 (Ar C-H), 2945, 2920, 2855, 2785, 2760 
gentle reflux with stirring under N2 over 15 min. A (C-H), 1645 (C=O), 1600 (C=C) 740, 710 (C-H out 
solution of 1-benzyl-4-piperidinone (43, 18.93 g, 100 of plane, mono); 1H NMR (DCCl3) 61.69 [d, IH, H(9), 
5,110,933 
24 23 
J = 12.7 Hz), 1.88 [d, IH, H(9), J = 12.7 Hz], 2.05-2.09 
(m, 2H. ring proton and H(l)), 2.24 (dd, lH, ring pro-
ton, J=l0.74 Hz, J'=2.66 (m, 2H, ring proton and 
H(5)). 3.08 [d, IH, ring proton, J = l 1.8 Hz]. 3.25-3.36 
(m, 3H, ring proton and H(I I)], 3.59 [d, 1H, H(l l), 
J= 13.2 Hz], 4.24 [d, IH, H(I0), J= 14.8 Hz]. 5.06 [d, 
JH. H(I0), J = 14.7 Hz], 7.08-7.38 (m. IOH, Ar-H); llC 
NMR (DCCl3) ppm 27.94 [C(9)), 28.07 [C(5)), 39.07 
(C( I)), 49.84 (C(I0)), 51.60 [C(4)), 57.07 [C(8)), 59.03 
(C(6)], 62.70 [C(l I)), 126.88, 127.14, 128.17, 128.40, 
128.49, 128.72, 137.39, 138.13 (Ar-C), 172.77 (C=O). 
Anal. Calcd. for C21H24N2O; C, 78.72; H, 7.55. Found: 
C, 78.39; H, 7.78. 
EXAMPLE XXXII 
7-Benzyl-9, 9-dimethoxy-3-thia-7-azabicyclo[3.3.1 ]-
nonane Hydroperchlorate (11) 
charged with a solution of the ketone ( 19, 1.0 g. 3.12 
mmol) in CH3OH (25 mL) and benzene (25 mL) to 
which was added HCIO4(60%, 1.5 g, 8.96 mmol) in one 
portion. The apparatus was flushed with N2 and the 
5 colorless solution was heated to reflux with cycling 
through the Soxhlet. After 24 h, the now pale yellow 
solution was cooled to RT and concentrated to a white 
solid which was filtered, washed with C6H6 (10 mL), 
and recrystallized (CH3OH, 80 mL) to afford the mono-
to perchlorate (0.91 g) as small white crystals, mp 
223.6"-224.0" C. (dee). The mother liquor was concen-
trated to approximately IO mL. Upon cooling to a -10• 
C. overnight, a second crop of salt (12) was obtained 
(89.4 mg, 68.6% total), mp 219°-220· C. (dee). The 
IS spectral data were as follows: IR (KBr) cm- 1 
2800-2600 (N-H), 1100 (Cl-0); 1H NMR (DMSO-d6) 
62.35 [bs, 2H, H(l,5)], 2.90 [d, 4H, H(2,4,6,8)a.r, J= 13 
Caution: The use of shields, protective goggles and Hz), 3.08 [d, 4H, H(2,4,6,8)~, J = 13 Hz], 3.14 (s, 6H, 
gloves is very strongly recommended when performing OCHJ), 3.88 (s, 4H, CH2Ph), 7.38-7.54 (m, IOH, 
this experiment. The formation of explosive methyl 20 Ar-H), 9.84 (bs, IH, N-H); 13C NMR (DMSO-d6) ppm 
perchlorate is a likely side reaction in this experiment. 33.0 [d, C(l,5)], 47.0(q, OCH3), 53.8 (t, C(2,4,6,8)], 59.6 
No difficulty ~as noted "':'hen the reaction was_ per- (t, CHiPh), 95.4 (C(9)), 128.2, 128.4, 129.6, 133.5 
formed as descnbed, but this may have been fortuitous. (Ar-C); lSN NMR (DMSO-d6) ppm 52.9 [N(3,7)). 
A one-necked, 100-mL, round-bot1omed flask was fitted Anal. Calcd. for CnHJiCIN2o6: c, 59.16; H, 6.69; Cl, 
with a Soxhlet co?taining 3A molecula~ sie~es (30 g), a 25 7.59; N, 6.00. Found: C, 58.98; H, 6.81; Cl, 7.86; N, 6.28. 
condenser, a heating mantle, a magnetic stirrer, and a 
heating mantle. The effective cycling volume of the 
Soxhlet ~•as approximately 15 mL. The flask was 
charged with a solution of the ketone (18, 1.0 g, 4 mmol) 
EXAMPLE XXXIV 
7-Benzyl-3-thia-7-azabicyclo(3.3. l)nonane 3-Oxide (49) 
in methanol (20 mL) and benzene (20 mL). To this 30 A 200-mL flask was equipped with a magnetic stirrer, 
solution was added HCIO4 (60%, 2.0 g. 12 mmol) in one an ice bath, and a condenser with nitrogen inlet. To a 
portion. The apparatus was flushed with N2and the pale stirred, chilled (5" C.) solution of the amine (27, 1.4 g, 6 
yellow solution was heated at reflux with stirring and mmol) in methanol (60 mL) was added dropwise a solu-
cycling through the Soxhlet for 24 h. The solution was tion of NaIO4 (1.35 g, 6.3 mmol) in water (15 mL) over 
cooled to RT and concentrated to about 5 mL. Ethyl 35 30 min. After stirring for one hour, the suspension was 
ether (20 mL) was added, thus precipitating the salt as a filtered and washed with methanol (50 mL); the wash-
powder. This was filtered, washed with ether (5 mL), ings and filtrate were combined and concentrated to a 
and dissolved in hot methanol (20 mL, decolorizing residue which was partitioned between H2CC]i and 
carbon). Trituration with ether (25 mL), followed by water (40 mL each). Additional extracts (HCCl3, 3 X 40 
standing fo~ 24 h, afforded the. salt ~11) (0.74 g, 46.2%) 40 mL) of the aqueous layer were combined with the initial 
as small while crystals; mp 193 -194 C. (dee); IR (KBr) extract, and the solution was dried (Na2SO4) and con-
cm- 12800-2600 (N-H), 1090 (Cl-O); 1H NMR centrated to afford an oil which solidified upon stand-
(DMSO-d6) 62.58 [bs, 2H, H(l,5)), 2.75 [d, 2H, H(2,4)ax, ing. Recrystallization (HCC13/pentane) of the solid 
J = 14 Hz], 3.15-3. 18 [m, 8H, H(2,4)~ and OCH3], 3.38 gave 1.15 g (76.9%) of crystalline (49); mp 140" -141 • C. 
[dd, or bt, 2H, H(6,8)ax, J = 12 Hz], 3.60 [d, 2H, H(6,8)eq, 45 JR (KBr) cm - I 3085, 3065, 3030, 2955, 2920, 2895, 2815, 
J= 12 Hz], 4.33 (d, 2H, CH2Ph, J=5 Hz), 7.49-7.62 (m, - 1495, l020, 740, 705; IH NMR (DCCIJ) 61.59 [bd, IH, 
5H, Ar-H); J3C NMR {DMOS-db) ppm 28.8 [t, H(9), J = 13.3 Hz], 1.86 [bd, lH, H(9), J = 13.2 Hz], 2.20 
C(2,4)), 32.2 [d, C(l,5)]. 46.6 (q, OCH3), 47.0 (q, OCH3), [d, 2H, H(2,4)ax, J = 11.7 Hz], 2.37 bs, 2H, H(l,5)), 2.62 
54.5 [t, C(6,8)), 60.2 (t, CH2Ph), 95.1 [s, C(9)], 129.0, [d 2H H(6 8) J = 12 o H ] 2 78 [d 2H H(2 4) 129.5, 130.l, 130.2 (d, Ar-C); ISN NMR (DMSO-d6) so • • • ax, · z • · • • • eq, 
53 " [N(7)) A I Cal d fi C H CINO S· c J = 11.8 Hz], 3.51 [d, 2H, H(6,8)eq, J = 11.7 Hz], 3.55 [s, ppm .J • na · c · or 26 24 6 . ' 2H, ArCH2], 7.26-7.39 (m, 5H, Ar-H); 13C NMR 48.79; H, 6.14; Cl, 9.00; N, 3.56; S, 8.14. Found: C, 48.73; (DCCIJ) ppm 31.86 [t, q 9)), 32_59 [d, C(l,5)], 57.42 [t, 
H, 6.09; Cl, 9-39; N, 3.S4; S, 8·40· C(2,4)), 58.59 [C(6,8)], 62.88 (ArCH2), 127.20, 128.39, 
EXAMPLE XXXIII 129.12, 137.67; 15N NMR (DCCl3) ppm 49.37 [N(7)]. 
3,7-Dibenzyl-9,9-dimethoxy-3,7-diazabicyclo[3.3.l]no- 55 Anal. Calcd. for C14ff19NOS: C, 67.43; H, 7.68. Found: 
nane Hydroperchlorate (12) C, 67.61; H, 7.73. 
Caution: The use of shields, protective goggles and 
gloves is very strongly recommended when performing 
this reaction. The formation of explosive methyl per- 60 
chlorate is a likely side reaction in this experiment. No 
difficulty was noted when the experiment was per-
formed as described, but this may have been fortuitous. 
A one-necked, 100-mL, round-bottomed flask was 
equipped with a Soxhlet containing 3A molecular sieve 65 
(30 g), a condenser with a N2 inlet, a magnetic stirrer, 
and a heating mantle. The effective cycling volume of 
the So:xhlet was approximately 20 mL. The flask was 
EXAMPLE XXXV 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonane 3-0:xide 
Hydroperchlorate (10) 
A 50-mL Erlenmeyer flask was equipped with a mag-
netic stirrer and an ice bath. To a stirred, chilled (5" C.) 
solution of the sulfo:xide (49, 0.47 g, 1.88 mmol) in ether 
(20 mL) and isopropyl aJcohol (3 mL) was added drop-
wise a solution of HCIO4 (60%, 0.63 g, 3.75 mmol) in 
isopropyl alcohol (3 mL) over 30 min. Filtering of the 





(50 ml) and then recrystallized (95% ethanol) to give a 
crystalline salt (10) (0.51 g, 78.1%); mp 137°-138° C. JR 
(KBr) cm- 1 3090, 2970, 2950, 1465, 1095, 745, 705; IH 
NMR (D3COD) 61.70 (bd, IH, H(9), J = 14.0 Hz]. 2.01 
[bd, IH, H(9), J=l3.9 Hz[. 2.61 [bd, 2H, H(2,4)ax, 5 
J = 11.8 Hz], 2.69 [bs, 2H. H(l ,5)]. 3.06 [bd, 2H, H(2.4)eq, 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate 6,8,10- 14C3 (48)• 
Caution: Special precautions should be taken when 
handling radioactive chemicals. All reactions should be 
carried out in a well ventilated hood with protective 
shields to prevent possible contamination of the lab 
J = I 1.8 Hz]. 3.36 [bd, 2H, H(6,8)ax, J = 13.1 Hz]. 3.94 (s, 
2H, ArCH2), 4.19 [bd, 2H, H(6,8),9, J=l2.9 Hz]. 
7.35-7.42 (m, SH, Ar-H); 13C NMR (D3COD) ppm 
30.80 (C(9)], 36.27 [C( 1,5)). 53.94 [C(2,4)], 58.56 
[C(6,8)), 61.07 [ArCH2], 129.43 129.78, 131.49, 135.29; 
1~N NMR (DMSO-d6) ppm 56.45 [N(7)]. Anal. Calcd. 
for C14H2oCINSOs: C, 48.06; H, 5.76. Found: C, 47.84; 
H, 5.74. 
10 
area. Protective safety goggles as well as quality rubber 
gloves should also be worn at all times since exposure to 
the 14C materials could be dangerous. To a mixture of 
KOH pellets (85%, 0.48 g, 8.5 mmol) and the ketone 
(18)• (0.18 g. 0.71 mmol) in triethylene glycol (5 ml) 
15 was added hydrazine (95%, 0.23 g, 7.1 mmol) in one 
portion in a SO-ml, jacketed flask equipped with a mag-
EXAMPLE XXXVI netic stirrer, a condenser, a lower take-off condenser 
7-Benzyl-3-thia-7-azabicyclo[3.3. l)nonan-9-one and two glass stoppers. A heating temperature of 
6,8, 10- 14e3 (18)* 140"-IS0" C. for 4 h was produced by boiling o-xylene 
. . . . 20 (bp 144" C.) in the jacket. After cooling to RT, the Caution. ~pec1~l precau~1ons should b_e taken when solution was diluted with chilled HiO (30 mL) and 
han~lmg rad_ioacuve chem1_cals. All reactt_ons should_be extracted with ether (4X20 mL). Combined extracts 
ca~ned out m a well v~ntilated h~ ~Ith protective were dried (Na2SO4, overnight) and filtered. Cooling of 
shields to p~evenl possible contammauon ~f the lab the ethereal solution to below s• c. was followed by the 
area. Protective safety goggles as well as quahty rubber dropwise addition of HCIQ4 (60%, 1 mL) over 10 min 
gloves should _also be won~ at all times since exposure to 25 with stirring, which resulted in the formation of a white 
the 14C matenals could be dangerous. A 50-mL, three- precipitate. Crude salt (48)* was filtered, recrystallized 
necked. round-bottomed flask was equipped with a (95% EtOH), and dried over P2Os (78" C./0. I mm Hg) 
magnetic stirrer, a heating mantle, a condenser with a to give 0.14 g (58.6%) of white crystals of salt (48)•; mp 
Ni inlet. and two glass stoppers. To a mixture contain- 30 154.5°-155.0" C.; (lit 155"-156" C.). A stock solution 
ing benzylamine (0.43 g. 4 mmol), [14C] benzylamine (3.49 mg/mL) of salt (48)• was prepared using DMSO, 
HCI [I mg, 7 X J0- 3 mmol, 0.5 mCi (minimum activity, H2O, and 0.IN HCI (40:53.5:6.5 by volume). Samples 
ICN)) in H2O (2.S mL). and deoxygenated methanol (15 were made by diluting 4 µl of the stock solution with 
ml) was added HCI (37%, 0.1 g, I mmol) followed by 10 mL of Aquasol 2 scintillation cocktail (New England 
glacial acetic acid (0.36 g, 6 mmol). Addition in one 35 Nuclear Research Products). Measurements of activity 
ponion of paraformaldehyde (0.96 g. 32 mmol) and were obtained at room temperature using a TRI-CARB 
[l4C] paraformaldehyde [I mg. 3.3x )0-2 mmol, 0.5 liquid scintillation analyzer, model 1900 CA (Packard 
mCi (minimum activity, ICN)) was followed by subse- Instrument Company). An average count of 19,800 
quent addition of 4-thianone (43, 0.47 g, 4 mmol) all at DPM was observed for each sample and the specific 
once with stirring. After the mixture was healed at 40 activity was determined to be 0.64 µCi/mg. In similar 
reflux under N2 for 6 h, the solution was concentrated to fashion, samples were prepared from stock solution of 
2-3 mL and then diluted with H2O (30 mL). The aque- the salt_ (48)• in methanol _and the specific activity was 
ous solution was extracted with ether (2 x 30 mL), and deter~med to be 0.63 µC1/'!1g. . . 
the Jauer was discarded. Chilling (via ice water bath) of To illustrate t~e us~ful ~1?log1c~I properties of _the 
the aqueous layer to below 5• c. was followed by basifi- 45 ~ompounds descnbed m this _mvenuon,_ selcc~e? den~a-
cation (pH-12) with NaOH pellets (97%, 0.29 g, 7 t1ves were screened _f~r anuarrhythm1c 3:cuv1t_y usmg 
mmol) which resulted in the formation of a cloudy dog models. The chmcally used agent hdocame and 
suspension. Combined extracts (ether, 4 X 30 mL) were 7-benzyl-3-thia-7-azabicyclo(3.3. l]nonane hydroper-
dried (Na2so4, overnight), filtered, and concentrated chlorate (48) [U.S._ Pat. No. 4,5~1,361] were ~mplo~ed 
( t t ) t • • -1 h. h so as standards as basis for companson. A small mfarct1on ro ary evapora or o give a viscous 01 , w 1c was . d h fi 
then di ested in 200 mL of Skell B (b 60._68• C.) for was c~cated J? an area_ ~f_the dog heart an t er~ ter g . Y P electrical pacmg was 1mt1ated to generate a sustained 
0.5 h. Concentration of the supernatant afforded a yel- t • 1 ta h d. (VT) Th. · Jar beati·ng • h' h . h . h. h ven ncu ar c year 1a . 1s 1rregu 
low ~JI w ic was SU~JCCted t? ~tmg at ig vacu~m pattern of the heart results in a reduction of the pump-
(110 C./0.1 mm Hgl_ m a su?~im~hon appar~tus to g!vc 55 ing capability of the heart in a ma~ner now accep!ed as 
0. 13 ~ ofketone ()~) , ~p 91 ~3 C. The residue which resembling symptoms observed m humans dunng a 
remained was agam dissolved m ether (~SO mL), and heart attack (see: Scherlag, B. J. ct. al, Am. J. Cardiol. 
the latter solution was dried (Na2SO4, overnight), fil. 1983, 51, 207; Bailey, B. R. ct. al., J. Med. Chem. 1984, 
tered, and concentrated to an oil. Digestion of the oil 27, 759; Thompson, M. D. ct. al., J. Med. Chem. 1987, 
was effected in 50 mL of Skelly B for 0.5 h, and the 60 30, 780; U.S. Pat. No. 4,581,361; and U.S. Pat. No. 
supe~atant was concentrated to a visc~us oil. This 4,778,892 for further details, said references incorpo-
matenal was heated under vacuum (110 C./0.1 mm rated herein for such purposes). The effects of the se-
Hg) in a sublimation apparatus and gave 0.05 g of lected compounds in terms of ability to reduce the rate 
slightly crude ketone ( 18)*; mp 7g• -so• C. A mixture of the induced VT or to eliminate the same (abolish the 
melting point determination with the first crop was 65 VT completely or at least not allow it to be sustained) is 
86• -88" C. without significant depression. This gave a then evaluated and compared to lidocaine or to 7-ben-
total yield of0.18 g (17.7%) of ketone (18)• which was zyl-3-thia-7-azabicyclo(3.3.l]nonane hydroperchlorate 




to lidocaine in most of the studies, data in Table A are 
compared to that obtained for the salt (48) cited herein. 
above compounds. The techniques employed in these 
preliminary studies are well documented, but a sum-
mary ofpharmacokinetic procedures can be found in: J. 
D. Baggot, .. Principals of Drug Disposition in Domes-
In Table A. it is clear that salts (1). (3). (5), (I I), (13), 
and (14) are extremely effective in eliminating the in-
duced VT as was the standard 7-benzyl-3-thia-7-
azabicyclo(3.3. I ]nonane hydroperchlorate (48) at 3 
mg/kg as well as at 6 mg/kg. Salts (10), (12), (15). and 
(17) reduced the rates of the induced VT but did not 
abolish them. In contrast, salt (8) exhibited little effect 
5 tic Animals: The Basis of Veterinary Clinical Pharma-
cology", W. B. Saunders Company, Philadelphia, 1977. 
These studies were conducted using 14C-labelled (48)• 
[Prepared by the method of Zisman, Berlin, et al. J. 
Labelled Compounds and Radiopharmaceuticals, In 
10 Press (1989)] in Sprague-Dawley rats. on the dog model which suggests there exists a high 
degree of specificity of action of these molecules in 
terms of antiarrhythmic activity. Thus, these heterocy-
clic molecules claimed in this application have elec-
trocardiology properties equal or superior to those of 
the standard 7-benzyl-3-thia-7-azabicyclo[3.3. l]nonane 15 
hydroperchlorate (48) which is known to have such 
superior properties to those of lidocaine (see: U.S. Pat. 
Nos. 4,581,361 and 4,778,891) which is a clinically used 
agent for the treatment of victims of heart attacks. 
Radioactivity-time data obtained by analysis of blood 
samples collected after intracardiac or oral administra-
tion are recorded in Tables B and C so designated. 
Coefficients and exponents of the disposition curves 
which best described changes in blood radioactivity 
with time after administration were obtained using a 
microcomputer program [R. D. Brown et al. J. Pharma-
ceutical Sciences, 67, 1687 (1978)). The disposition of 
(48)• after intracardiac administration was well de-
In principle, it is felt that the compositions of the 
present invention can be employed separately or incom-
bination with each other or in combination with other 
drugs to achieve either individually or in combination 
the desired antiarrhythmic properties. It is expected 
that the composition can be utilized and administered 
via a variety of methods including by way of an exam-
ple, but not limited thereto, intravenously, orally, by 
suppository, by inhalation, and the like. Furthermore, it 
20 scribed by a two-compartment open model and the 
pharmacokinetic parameters derived from the analysis 
of individual blood radioactivity data are presented in 
Table D so designated. The median half-life of elimina-
tion (Tl(,BJ) of radioactivity was 5.7 hours, which sug-
25 gested that a moderate to reasonably long dosage inter-
val might be appropriate for therapeutic use. The me-
dian apparent volume of distribution, based on total 
area under the disposition curve (V d(a,..,0 )), was high 
(4070 ml/kg) indicating extensive distribution into body is generally felt that the compositions as claimed either 
specifically possess antiarrhythmic activity or generally 
are broad biologically active or the respective composi-
tions are intermediates to antiarrhythmic and biologi-
cally active species that are released or created in situ as 
the result of administration of the drug. 
30 tissues. The high total body clearance value (Cls=470) 
confirms the presence of efficient drug elmination path-
ways. 
Pharmacokinetic terms describing changes in blood 
radioactivity after oral administration are presented in 
TABLE A 
A~TIARRHYTH\11C PROPERTIES 
OF REPRESEST ATIVE 3-AZABICYCLO[J.3 l]NO~ANE SAL TS 
0 ~ 4 
I \ \ 
Y 92 N-R HX 
\_L I 
8 I 2 Q 
(Effect on SVTb) 
Comp• R y z 3mg/l.g 
(I) CH(CH, •2 NC(O)Ph CH2 NSVT 
m CH(CH.,)2 NCH2C0Jii-3,4(0CH,l: CH2 NSVT 
m CH(CH3)2 NCH2Ph CH2 NSVT 
(8) CH(CH1h s CH2 No action 




rale of VT 
(11) CH2Ph s C(OCH3)i NSVT 
02) CH2Ph NCH2Ph C(OCH3)2 Reduced 
rale of VT 
(13) CH2PH CHCC)iE1 CH2 NSVT 
(14) CH2Ph CHC02E1 C(SCH2h NSVT 
(IS) NC(O)Ph s CH2 Reduced 
rate of VT 
(17,' CH2Ph NCH2Ph CH2 Reduced 
rate of VT 
'X - CI04. Cl. Br. citra10. fum.ora1•. HSO• 
'sVT - Susia1Md ven1ncular iachycardui 1nduad by electrical poc1n1 of infan:tod do1 i-n 
'NSVT • Non1:i.i11anw:d venlncular tachycard .. (or aboh'lhed vmtncular tKhycard11) 








rate of VT 
NSVT 
Reduced 




rate or VT 
Reduced 
ra1e or VT 
In order to determine the potential viability of mem- 65 
bers of the above family to act as useful antiarrhythmic 
agents in vivo, a pharmacokinetic and metabolism study 
was undertaken using a representative example from the 
Table D so designated. Compartmental analysis showed 
that the data fitted a one-compartment pharmacokinetic 
29 
5,110,933 
model. Oral dosing resulted in rapid and extensive ab-
sorption and peak concentrations within 30 minutes 
after administration. The ratio of the areas under the 
radioactivity-time curves obtained after oral and intra-
cardiac administration (AUCpo!AUC;c) indicates a high 
bioavailability ( ±81 % ). Thus, the oral route of adminis-
tration may be suitable for therapeutic management of 
patients suffering from cardiac arrhythmias. 
TABLE B 
Kinetic, or appearance of rachoactivity [dpm/ml] in blood 
after intracardiac administration or a bolus dosage 
!10 ms/ks) or (48)•p332000dl!m/ms) 
Time arter 
administration Individual rats 
(houB) #2 #3 #8 #9 #10 #15 #16 Mean 
0.0333 6802 6732 6419 6173 6595 7140 6644 
0.0833 5482 5424 5496 5661 6106 7262 5905 
0.1667 4741 5520 6087 4903 4780 5752 6435 S460 
0.3333 4807 4225 4261 4768 5219 6197 4913 
0.5 5294 3233 42IO 4228 5152 3938 4343 
I 2911 3619 4182 4343 3002 3433 3873 3623 
2 1862 2004 2495 2451 2721 2463 1907 2272 
3 1307 2357 2369 2314 2087 
4 1374 1382 2316 2429 2379 1578 1438 1842 
6 1719 2089 1905 2186 l6Q() 1377 1828 
IO 1005 1113 ll23 1191 903 1040 900 !039 
16 534 332 515 353 395 349 413 
24 242 308 71 60 178 197 144 171 
TABLE C 
Kinetic, or apr,earance of radioacti,11) [dpm/ml] in blood 
after oral admin"tration of a bolu, dosage 











Kinetics of appearance or radioac11vity fdpm/ml] 1n blood 



























j 10 mw'lSl of (481"( l3J2000dpmlms) 
Individual rats 
#4 #6 #7 #II #12 #13 Mean SD 
2208 1545 1618 2896 991 2043 1884 654 
1786 2034 2114 2017 1767 1713 1905 169 
1601 1502 1224 1594 1714 ll38 1462 230 
893 662 885 1118 1613 984 1026 324 
418 245 302 140 586 390 347 154 
300 89 79 66 197 75 134 95 
TABLED 
Pharmacolinetic ,·alues derived from each rars (48)" blood di,po,iuon curves. 
Determinant 2 
A (dpm/ml) 3670 
B (dpm/m]) 2192 
a (hr- 11 1.36 
P(hr-t) 0.090 
K21 (hr- 1) 0.568 
K,i(hr- 1} 0.217 
K12(hr- 1} 0.673 
lj(.81 (hr} 7.67 
t11al (hr) 0.50 
C0 (dpm/ml) 5863 
V,(ml/kg) 2271 
V dl•""l (ml/kg) 5471 
V d( n) (ml/kg) 4963 
Cla(ml/hr, kg} 494 
AUC;< 25282 
De-1erminant 4 
p (hr- II 0.107 
lj(P) (hr) 6.42 
AUCpo 25306 
AUCeAUC;, 
•Val~ rey,retirrn med:1.1.ns 
(hou~} #4 #6 #7 #II #12 #13 Mean SD 
65 
0.1667 1928 802 l026 1601 479 967 1134 534 
0.3333 2153 1723 2311 3265 754 1946 2025 818 
0.5 4281 2086 2659 4421 1025 2151 2771 1335 





















]. lntracard1ac admlnis1ration: 
lmdividual rats 
8 9 JO 
2583 2532 2350 
4333 4647 3659 
1.93 11.49 2.18 
0.163 0.164 0.131 
l.276 7.499 1.380 
0.248 0.252 0.207 
0.578 3.908 0.726 
4.23 4.20 5.28 
0.35 0.06 0.31 
6917 7179 6010 
1925 1855 2216 
2926 2843 3504 
2798 2822 3381 
















29169 30489 28444 27126 24104 
I. Oral administration: 
lndi•·idual rats 
7 ]I 12 13 
0.143 0.181 0.149 0.137 
4.81 3.80 4.63 5.04 
















Tissue distribution of (48)* was studied by measuring 
the radioactivity in selected organs collected from rats 
sacrificed at several time intervals after oral administra-
tion. Data obtained from these studies is reported in 
Table E so designated. High levels of radioactivity 
5,110,933 
31 
were measured in liver and kidney which is consistent 
with the extensive metabolism and excretion of metabo-
lites commonly encountered with highly lipid soluble 
xenobiotics [agent (48)• has both polar and nonpolar 
structural features). Thes.e observations correlate well 5 
with the high volume of distribution calculated from 
pharmacokinetic data. Reas.onably high concentrations 
of radioactivity in the heart confirm that (48)• achieves 
good penetration into the target organ. Radioactivity in 
the brain and perirenal fat were low in comparison with 10 
other tissues and decreased steadily with time after 
administration. This suggei;ts that central neurotoxicity 
may not limit the therapeutic use of these agents and 
that Jong-term accumulation in fat depots may not pres-
ent a toxicological hazard. 15 
Thin layer chromatographic analysis of urine samples 
collected after oral administration of 14C-labelled (48)• 
32 
TABLE E-continued 
Concentration or radioactivity m . ..,Jected organ, 
and tissues after oral administration of a bolu, 
dffillJ!e ( JO mJ!lkJ!) of (48) 0 ( I 332000d[!mlm,liJ· 
Time after 
adminis- E,I:':!anmental unit, 
tration (hr) II III Mean 
0.5 l60t> 2068 2145 1940 
0.75 1070 186() 2599 1845 
1.5 718 933 745 799 
4 610 508 562 560 
8 577 172 558 436 
16 216 138 271 208 
24 77 119 97 98 
I. Brain concenlrattons !d2ml&): 
0.083 1280 296 1496 1024 
0.25 1562 1980 1028 1523 
0.5 824 971 643 813 
0.75 711 1051 551 771 
1.5 477 506 626 536 
4 399 343 399 380 
8 248 232 274 251 
16 108 106 92 102 


















to rats indicated that most of the dose was excreted in 
the form of metabolites. Using mass spectrometry, the 
major metabolite was identified as l4C.Jabelled (15)•, 20 
the structure of which was confirmed by comparison 
with an authenticated sample of unlabelled (15). Conse-
quently, amide (15) is an active metabolite of (48) and is 
therefore a potentially viable agent in its own right. The 3-azabicyclo[3.3.l)nonane compounds described 
25 herein may be generally characterized by the formula: TABLE E 
Concentrauon of rad1oactiv1t} in ..,Jected organ, 
and ti.sues after oral admmistrauon or a bolus 
dosase ()0 ms/I.El of (48)"!1332000d[!mlmgl 
Time after 
admm1'- E,1!5:rtmental units 
trauon 4hr) II Ill Mean 
1 Blood com·entratiom (d[!m/ml) 
008:I 2B0 1970 3975 2758 
0.25 5170 6755 4615 5513 
05 6()20 6010 49:15 5655 
0.75 4370 3335 4245 3983 
u 2840 2790 3300 2977 
4 206() 2580 1800 2147 
8 740 650 740 710 
16 276 219 295 263 
I K1dnc, concentrations !d[!ml&!' 
0.083 11320 5425 21341 12695 
0.25 27222 34142 20528 27297 
0.5 31622 39516 28700 33279 
0.75 26793 19249 24987 23676 
1.5 18881 16254 2156(, 18900 
4 15219 17715 12217 15050 
8 4963 4835 5i'l6 5031 
16 2591 1761 2285 2212 
24 1250 2489 1004 1581 
I. Liver concentrations !d[!mlg): 
0.083 49025 37302 33768 40032 
0.25 77479 86705 53662 72615 
0.5 12327 81324 68846 77499 
0.75 40648 16117 46449 34405 
1.5 14156 18970 21791 18306 
4 14430 17811 15814 16018 
8 10272 9195 9855 9774 
16 6886 4065 4948 5300 
24 3427 4709 2563 356() 
I. Hean concentrations !d[!ml&l' 
0.083 4813 1236 4292 3447 
0.25 5402 5647 3890 4980 
0.5 5071 4903 4107 4694 
0.75 3442 2785 3608 3278 
1.5 2415 2511 2736 2554 
4 1120 211'4 1676 1170 
8 826 668 790 761 
16 336 273 412 340 
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H-X represents a pharmacologically acceptable acid, 








R represents hydrogen, ]ower alkyl, or a benzyl- or 
benzoyl group wherein the phenyl ring is unsubsti-
tuted or is substituted by halogen or by I to 3 me-





55 Y represents S, S-0, CH-CO2C2Hs, or a group 
N-R' wherein R' is ]ower alkyl or a benzyl- or ben• 
zoyl group, in which group the phenyl ring is unsub-
stituted or is substituted by halogen or by 1 to 3 me-
thoxy groups. 
60 The claims and the specification describe the inven-
tion presented and the terms that are employed in the 
claims draw their meaning from the use of such terms in 
the specification. The same terms employed in the prior 
art may be broader in meaning than specifically em-
65 ployed herein. Whenever there is a question between 
------------- the broader definition of such terms used in the prior art Perirenal rat concentrations !d[!mlg) 
0.083 2583 647 





and the more specific use of the terms herein, the more 




While the invention has been described with a certain 
degree of particularity it is manifest that many changes 
may be made in the details of construction and the ar-
rangement of components without departing from the 5 
spirit and scope of this disclosure. It is understood that 
the invention is not limited to the embodiments set forth 
herein for purposes of exemplification, but is to be lim-
ited only by the scope of the attached claim or claims, 10 
including the full range of equivalency to which each 
element thereof is entitled. 
What is claimed is: 
J. A 3-azabicyclo [3.3.l]nonane compound having 
the following formula: 15 




R represents hydrogen, lower alkyl. or a benzyl- or 
benzoyl group wherein the phenyl ring is unsubsti• 
tuted or is substituted by halogen or by I to 3 me-





Y represents S-0. 
\' 2 N-R.H-X 
~✓ 
20 l. A compound according to claim J wherein Q rep-
resents CH2. 
wherein 
H-X represents a pharmacologically acceptable acid, 
Q represents CH2, or CO, 
Z represents CH2, CO. C(OCH3)2. or 
3. A compound according to claim 1 wherein Z rep-
resents CH2. 
4. A compound according to claim 1 wherein R rep-
25 resents C 1-C4-alkyl or an optionally substituted benzyl-
or benzoyl group. 
• • • • • 
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